Laboratory Corp. Of America Holdings. (LH) NEW YORK STOCK EXCHANGE INC.

$244.50 -4.84 (-1.94%)

Market Cap: $22.09B

As of 02/06/23 04:00 PM EST. Market closed.

(LH)

Laboratory Corp. Of America Holdings. (LH) NEW YORK STOCK EXCHANGE INC.

$244.50 -4.84 (-1.94%)

Market Cap: $22.09B

As of 02/06/23 04:00 PM EST. Market closed.

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, ... read more

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, Labcorp serves clients in more than 100 countries. Labcorp reported revenue of $14 billion in FY2020. read less

COMPANY PROFILE
Sector
Health Care and Social Assistance
Industry
Diagnostic Imaging Centers
CEO
Adam Schechter
Full Time Employees
75,500
CEO Compensation (Base)
$1.18M
CEO Compensation (Total)
$12.26M
URL
Address
358 S Main St, North Carolina, Burlington, 27215-5837.
Sector
Health Care and Social Assistance
Industry
Diagnostic Imaging Centers
CEO
Adam Schechter
Full Time Employees
75,500
CEO Compensation (Base)
$1.18M
CEO Compensation (Total)
$12.26M
Address
358 S Main St, North Carolina, Burlington, 27215-5837.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$247.47
Previous Close
$249.34
Days Range
$243.26 - $249.42
52 week range
$199.73 - $287.71
Volume
1,060,718
Avg. Volume (30 days)
551,764
Market Cap
$22.09B
Dividend Yield
0.86%
P/E
12.58
Shares Outstanding
88,600,000
Open
$247.47
Previous Close
$249.34
Days Range
$243.26 - $249.42
52 week range
$199.73 - $287.71
Volume
1,060,718
Avg. Volume (30 days)
551,764
Market Cap
$22.09B
Dividend Yield
0.86%
P/E
12.58
Shares Outstanding
88,600,000

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR LABORATORY CORP. OF AMERICA HOLDINGS
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Seltz Judith CEVP, CHROFeb 02, 2023 Option Exercise$254.997719,6341,602Feb 06, 2023, 04:00 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 02, 2023 Option Exercise$254.996416,3195,514Feb 06, 2023, 03:56 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 03, 2023 Sale$253.9017343,9255,341Feb 06, 2023, 03:56 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 02, 2023 Option Exercise$254.994110,4551,990Feb 06, 2023, 03:55 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 02, 2023 Option Exercise$254.997719,634393Feb 06, 2023, 03:54 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 02, 2023 Option Exercise$254.9911930,3447,011Feb 06, 2023, 03:51 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 03, 2023 Sale$253.9032482,2646,687Feb 06, 2023, 03:51 PM
Schechter Adam HPresident & CEOFeb 02, 2023 Option Exercise$254.99805205,26719,556Feb 06, 2023, 03:49 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 02, 2023 Option Exercise$254.9914135,95413,332Feb 06, 2023, 03:45 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 02, 2023 Option Exercise$254.9920652,52834,403Feb 06, 2023, 03:43 PM
Caveney Brian JEVP, President of DiagnosticsFeb 02, 2023 Option Exercise$254.9914436,71915,718Feb 06, 2023, 03:41 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 02, 2023 Option Exercise$254.9910226,00919,697Feb 06, 2023, 03:40 PM
Schroeder Mark SEVP, President-Diagnostics LabNov 08, 2022 Sale$232.671,116259,6606,687Nov 10, 2022, 08:40 AM
Schroeder Mark SEVP, President-Diagnostics LabNov 07, 2022 Option Exercise$233.77894208,9907,803Nov 08, 2022, 04:27 PM
Caveney Brian JEVP, President of DiagnosticsNov 07, 2022 Option Exercise$233.77894208,99015,398Nov 08, 2022, 04:20 PM
EISENBERG GLENN AChief Financial Officer, EVPNov 01, 2022 Option Exercise$222.565,3481,190,25133,842Nov 03, 2022, 05:04 PM
Schechter Adam HPresident & CEONov 01, 2022 Option Exercise$222.56893198,74617,588Nov 03, 2022, 05:01 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentNov 01, 2022 Option Exercise$222.56892198,52413,030Nov 03, 2022, 05:00 PM
EISENBERG GLENN AChief Financial Officer, EVPSep 26, 2022 Sale$210.6225,0005,265,58146,531Sep 28, 2022, 09:12 AM
Caveney Brian JEVP, President of DiagnosticsSep 07, 2022 Buy$231.204410,17314,282Sep 13, 2022, 11:39 AM
EISENBERG GLENN AChief Financial Officer, EVPAug 03, 2022 Option Exercise$147.1232,1004,722,54384,258Aug 05, 2022, 09:52 AM
EISENBERG GLENN AChief Financial Officer, EVPAug 03, 2022 Sale$253.9432,1008,151,45072,996Aug 05, 2022, 09:52 AM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 01, 2022 Option Exercise$257.94235,9331,914Aug 03, 2022, 11:54 AM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 01, 2022 Option Exercise$146.59767112,4352,654Aug 03, 2022, 11:54 AM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 01, 2022 Sale$258.402,576665,6341,897Aug 03, 2022, 11:54 AM
Caveney Brian JEVP, President of DiagnosticsJun 07, 2022 Buy$242.194210,17214,172Jun 14, 2022, 08:46 AM
Schroeder Mark SEVP, President-Diagnostics LabMar 29, 2022 Sale$277.112,356652,8716,605Mar 31, 2022, 10:24 AM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 29, 2022 Sale$277.112,449678,6425,287Mar 31, 2022, 10:20 AM
BERBERIAN LANCEEVP, CIO & CTOMar 28, 2022 Option Exercise$276.422,360652,35119,502Mar 29, 2022, 12:09 PM
Caveney Brian JEVP, President of DiagnosticsMar 28, 2022 Option Exercise$276.421,883520,49914,130Mar 29, 2022, 12:07 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 28, 2022 Option Exercise$276.426,2861,737,57652,158Mar 29, 2022, 12:05 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentMar 28, 2022 Option Exercise$276.421,648455,54011,915Mar 29, 2022, 12:04 PM
Schroeder Mark SEVP, President-Diagnostics LabMar 28, 2022 Option Exercise$276.421,885521,0528,961Mar 29, 2022, 12:03 PM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 28, 2022 Option Exercise$276.421,792495,3457,736Mar 29, 2022, 12:02 PM
Wilkinson Peter JSVP, Chief Accounting OfficerMar 28, 2022 Option Exercise$276.42915252,9243,696Mar 29, 2022, 12:00 PM
Williams R SandersDirectorMar 25, 2022 Sale$272.98572156,1456,431Mar 29, 2022, 09:46 AM
Summy Amy B.EVP, Chief Marketing OfficerMar 10, 2022 Sale$262.2124965,290250Mar 14, 2022, 04:36 PM
NEUPERT PETER MDirectorFeb 16, 2022 Buy$263.663,500922,81510,254Feb 18, 2022, 08:46 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 15, 2022 Sale$273.9820756,7146,605Feb 17, 2022, 03:05 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 15, 2022 Sale$273.9820756,7145,287Feb 17, 2022, 03:03 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 14, 2022 Option Exercise$272.6826171,1691,989Feb 15, 2022, 04:51 PM
Caveney Brian JEVP, President of DiagnosticsFeb 14, 2022 Option Exercise$272.68778212,14512,466Feb 15, 2022, 04:48 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 14, 2022 Option Exercise$272.6827775,53244,300Feb 15, 2022, 04:43 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 14, 2022 Option Exercise$272.6810829,4499,856Feb 15, 2022, 04:42 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 14, 2022 Option Exercise$272.68799217,87116,657Feb 15, 2022, 04:40 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 14, 2022 Option Exercise$272.687720,9966,812Feb 15, 2022, 04:38 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 14, 2022 Option Exercise$272.687720,9965,494Feb 15, 2022, 04:37 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 04, 2022 Option Exercise$277.4810930,24514,643Feb 08, 2022, 11:19 AM
Caveney Brian JEVP, President of DiagnosticsFeb 04, 2022 Option Exercise$277.4816545,7849,912Feb 08, 2022, 11:18 AM
EISENBERG GLENN AChief Financial Officer, EVPFeb 04, 2022 Option Exercise$277.4828679,35943,637Feb 08, 2022, 11:16 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 04, 2022 Option Exercise$277.4816545,7849,647Feb 08, 2022, 11:13 AM
Schechter Adam HPresident & CEOFeb 04, 2022 Option Exercise$277.481,412391,80216,474Feb 08, 2022, 11:10 AM
Schroeder Mark SEVP, President-Diagnostics LabFeb 04, 2022 Option Exercise$277.4815242,1776,809Feb 08, 2022, 11:08 AM
Schroeder Mark SEVP, President-Diagnostics LabFeb 07, 2022 Sale$277.3820456,5866,605Feb 08, 2022, 11:08 AM
Seltz Judith CEVP, CHROFeb 04, 2022 Option Exercise$277.488523,5861,377Feb 08, 2022, 11:06 AM
Summy Amy B.EVP, Chief Marketing OfficerFeb 04, 2022 Option Exercise$277.488323,031499Feb 08, 2022, 11:03 AM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 04, 2022 Option Exercise$277.488222,7535,505Feb 08, 2022, 11:01 AM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 07, 2022 Sale$277.3821860,4695,287Feb 08, 2022, 11:01 AM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 04, 2022 Option Exercise$277.485314,7061,183Feb 08, 2022, 11:00 AM
Schroeder Mark SEVP, President-Diagnostics LabFeb 02, 2022 Option Exercise$273.1812133,0556,562Feb 04, 2022, 12:15 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 03, 2022 Sale$271.8116143,7616,401Feb 04, 2022, 12:15 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 02, 2022 Option Exercise$273.186417,4845,459Feb 04, 2022, 12:14 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 03, 2022 Sale$271.8117246,7515,287Feb 04, 2022, 12:14 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 02, 2022 Option Exercise$273.187721,035315Feb 04, 2022, 09:45 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 02, 2022 Option Exercise$273.1814439,3389,252Feb 04, 2022, 09:44 AM
Seltz Judith CEVP, CHROFeb 02, 2022 Option Exercise$273.187620,7621,182Feb 04, 2022, 09:43 AM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 02, 2022 Option Exercise$273.184111,2001,086Feb 04, 2022, 09:42 AM
Caveney Brian JEVP, President of DiagnosticsFeb 02, 2022 Option Exercise$273.1814740,1579,517Feb 04, 2022, 09:37 AM
Schechter Adam HPresident & CEOFeb 02, 2022 Option Exercise$273.18803219,36414,379Feb 04, 2022, 09:36 AM
EISENBERG GLENN AChief Financial Officer, EVPFeb 02, 2022 Option Exercise$273.1823664,47042,953Feb 04, 2022, 09:34 AM
BERBERIAN LANCEEVP, CIO & CTOFeb 02, 2022 Option Exercise$273.1810328,13814,379Feb 04, 2022, 09:33 AM
BELINGARD JEAN-LUCDirectorFeb 02, 2022 Option Exercise$273.187821,30816,262Feb 04, 2022, 09:00 AM
Gilliland Dwight GaryDirectorDec 15, 2021 Sale$302.26500151,1286,395Dec 17, 2021, 10:36 AM
Caveney Brian JEVP, President of DiagnosticsNov 05, 2021 Option Exercise$274.84899247,0819,182Nov 09, 2021, 02:49 PM
Schroeder Mark SEVP, President-Diagnostics LabNov 05, 2021 Option Exercise$274.84899247,0816,240Nov 09, 2021, 02:46 PM
Schechter Adam HPresident & CEONov 01, 2021 Option Exercise$288.78886255,85912,409Nov 03, 2021, 11:51 AM
EISENBERG GLENN AChief Financial Officer, EVPNov 01, 2021 Option Exercise$288.784,0341,164,93942,423Nov 03, 2021, 11:49 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentNov 01, 2021 Option Exercise$288.78898259,3248,953Nov 03, 2021, 11:47 AM
van der Vaart Sandra DEVP, Chief Legal OfficerSep 15, 2021 Option Exercise$84.864,500381,8709,765Sep 17, 2021, 12:20 PM
van der Vaart Sandra DEVP, Chief Legal OfficerSep 15, 2021 Sale$296.784,5001,335,5105,265Sep 17, 2021, 12:20 PM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 02, 2021 Option Exercise$297.61154,4641,011Aug 03, 2021, 04:16 PM
van der Vaart Sandra DEVP, Chief Legal OfficerJun 07, 2021 Option Exercise$84.864,500381,8709,737Jun 09, 2021, 02:03 PM
van der Vaart Sandra DEVP, Chief Legal OfficerJun 07, 2021 Sale$266.564,5001,199,5205,237Jun 09, 2021, 02:03 PM
BELINGARD JEAN-LUCDirectorMay 03, 2021 Option Exercise$98.492,600256,07418,169May 05, 2021, 10:48 AM
BELINGARD JEAN-LUCDirectorMay 03, 2021 Sale$269.152,600699,80315,569May 05, 2021, 10:48 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentApr 03, 2021 Option Exercise$252.67452114,20710,344Apr 06, 2021, 12:18 PM
Schroeder Mark SEVP, President-Diagnostics LabMar 30, 2021 Sale$251.88667168,0045,006Apr 01, 2021, 08:32 AM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 30, 2021 Sale$251.88812204,5275,237Apr 01, 2021, 08:32 AM
EISENBERG GLENN AChief Financial Officer, EVPMar 27, 2021 Option Exercise$251.583,595904,43037,433Mar 30, 2021, 06:46 PM
BERBERIAN LANCEEVP, CIO & CTOMar 27, 2021 Option Exercise$251.581,079271,45514,186Mar 30, 2021, 06:45 PM
Caveney Brian JEVP, President of DiagnosticsMar 27, 2021 Option Exercise$251.581,079271,4558,001Mar 30, 2021, 06:43 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentMar 27, 2021 Option Exercise$251.58790198,7489,786Mar 30, 2021, 06:42 PM
Schroeder Mark SEVP, President-Diagnostics LabMar 27, 2021 Option Exercise$251.581,079271,4555,673Mar 30, 2021, 06:41 PM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 27, 2021 Option Exercise$251.58687172,8356,049Mar 30, 2021, 06:40 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 12, 2021 Option Exercise$238.2626362,6621,127Feb 19, 2021, 02:17 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 18, 2021 Option Exercise$157.092,166340,2512,660Feb 19, 2021, 02:17 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 18, 2021 Sale$241.512,317559,590343Feb 19, 2021, 02:17 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 12, 2021 Option Exercise$238.2615837,6454,634Feb 17, 2021, 04:28 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 16, 2021 Sale$236.5520849,2024,531Feb 17, 2021, 04:28 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 12, 2021 Option Exercise$238.2614233,8334,527Feb 17, 2021, 04:27 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 16, 2021 Sale$237.0618844,5674,424Feb 17, 2021, 04:27 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 12, 2021 Option Exercise$238.2618042,8878,472Feb 17, 2021, 04:25 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2021 Option Exercise$238.26512121,98932,986Feb 17, 2021, 04:23 PM
Caveney Brian JEVP, President of DiagnosticsFeb 12, 2021 Option Exercise$238.26854203,4746,667Feb 17, 2021, 04:22 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 12, 2021 Option Exercise$238.26873208,00112,852Feb 17, 2021, 04:21 PM
Schechter Adam HPresident & CEOFeb 04, 2021 Option Exercise$223.781,028230,04611,288Feb 08, 2021, 03:48 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 04, 2021 Option Exercise$223.785311,860523Feb 08, 2021, 03:46 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 04, 2021 Option Exercise$223.788318,5744,328Feb 08, 2021, 03:43 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 05, 2021 Sale$225.8510924,6184,219Feb 08, 2021, 03:43 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 04, 2021 Option Exercise$223.789421,035172Feb 08, 2021, 03:42 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 04, 2021 Option Exercise$223.7815434,4624,355Feb 08, 2021, 03:40 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 05, 2021 Sale$225.8520345,8484,152Feb 08, 2021, 03:40 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 04, 2021 Option Exercise$223.7818741,8478,071Feb 08, 2021, 03:39 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 04, 2021 Option Exercise$223.7830668,47731,778Feb 08, 2021, 03:36 PM
Caveney Brian JEVP, President of DiagnosticsFeb 04, 2021 Option Exercise$223.7819042,5184,651Feb 08, 2021, 03:35 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 04, 2021 Option Exercise$223.7813129,31510,785Feb 08, 2021, 03:34 PM
Seltz Judith CEVP, CHROFeb 04, 2021 Option Exercise$223.789621,483915Feb 08, 2021, 03:33 PM
BELINGARD JEAN-LUCDirectorFeb 04, 2021 Option Exercise$223.789922,15415,569Feb 08, 2021, 03:14 PM
Williams R SandersDirectorJan 26, 2021 Option Exercise$98.491,300128,0375,246Jan 28, 2021, 12:11 PM
Schroeder Mark SEVP, President-Diagnostics LabNov 06, 2020 Sale$214.59588126,1793,949Nov 10, 2020, 10:48 AM
Caveney Brian JEVP, President of DiagnosticsNov 05, 2020 Option Exercise$214.42886189,9764,221Nov 09, 2020, 09:21 AM
Schroeder Mark SEVP, President-Diagnostics LabNov 05, 2020 Option Exercise$214.42835179,0414,537Nov 09, 2020, 09:19 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentNov 04, 2020 Sale$214.141,500321,2047,698Nov 06, 2020, 09:06 AM
EISENBERG GLENN AChief Financial Officer, EVPNov 02, 2020 Option Exercise$207.234,034835,96631,114Nov 04, 2020, 05:47 PM
Schechter Adam HPresident & CEONov 02, 2020 Option Exercise$207.23885183,3998,810Nov 04, 2020, 05:43 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentNov 02, 2020 Option Exercise$207.23895185,4719,198Nov 04, 2020, 05:40 PM
Caveney Brian JEVP, President of DiagnosticsSep 25, 2020 Option Exercise$180.9928952,3063,097Sep 29, 2020, 01:42 PM
Williams R SandersDirectorJul 08, 2020 Option Exercise$98.491,300128,0376,395Jul 10, 2020, 04:25 PM
Williams R SandersDirectorJul 08, 2020 Sale$173.121,300225,0565,095Jul 10, 2020, 04:25 PM
van der Vaart Sandra DEVP, Chief Legal OfficerJul 02, 2020 Sale$170.0043573,9504,044Jul 07, 2020, 09:38 AM
van der Vaart Sandra DEVP, Chief Legal OfficerJun 24, 2020 Sale$160.33872139,8084,915Jun 26, 2020, 10:06 AM
KING DAVID PDirectorMay 05, 2020 Sale$160.0031,2505,000,000312,554May 07, 2020, 12:05 PM
Seltz Judith CEVP, CHROMar 10, 2020 Buy$168.5633055,625580May 04, 2020, 10:18 AM
Seltz Judith CEVP, CHROFeb 28, 2020 Buy$174.9425043,735250May 04, 2020, 10:18 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentApr 03, 2020 Option Exercise$113.3137242,1518,087Apr 07, 2020, 04:21 PM
KING DAVID PDirectorMar 30, 2020 Option Exercise$131.9524,5833,243,727343,804Apr 01, 2020, 02:40 PM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 30, 2020 Option Exercise$131.951,106145,9375,351Apr 01, 2020, 02:39 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 30, 2020 Option Exercise$131.955,787763,59526,124Apr 01, 2020, 02:33 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentMar 30, 2020 Option Exercise$131.951,014133,7977,449Apr 01, 2020, 02:29 PM
Schroeder Mark SEVP, President-Diagnostics LabMar 30, 2020 Option Exercise$131.951,153152,1383,213Apr 01, 2020, 02:28 PM
BERBERIAN LANCEEVP, CIO & CTOMar 30, 2020 Option Exercise$131.951,695223,65510,543Apr 01, 2020, 02:23 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 21, 2020 Sale$189.6529756,326297Feb 25, 2020, 12:59 PM
BELINGARD JEAN-LUCDirectorFeb 19, 2020 Option Exercise$77.193,100239,28941,161Feb 21, 2020, 03:52 PM
BELINGARD JEAN-LUCDirectorFeb 19, 2020 Sale$189.7626,4795,024,76114,682Feb 21, 2020, 03:52 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2020 Option Exercise$187.5151296,00518,966Feb 14, 2020, 05:32 PM
van der Vaart Sandra DSVP, Global General CounselFeb 12, 2020 Option Exercise$187.5115829,6272,944Feb 14, 2020, 05:11 PM
van der Vaart Sandra DSVP, Global General CounselFeb 13, 2020 Sale$188.4920839,2062,839Feb 14, 2020, 05:11 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 12, 2020 Option Exercise$187.5114226,626674Feb 14, 2020, 05:07 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 13, 2020 Sale$188.4918835,436589Feb 14, 2020, 05:07 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 12, 2020 Option Exercise$187.51872163,5098,358Feb 14, 2020, 04:11 PM
Caveney Brian JEVP, President of DiagnosticsFeb 12, 2020 Option Exercise$187.51866162,3842,326Feb 14, 2020, 03:51 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 12, 2020 Option Exercise$187.5127251,003594Feb 14, 2020, 03:50 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 12, 2020 Option Exercise$187.5115929,8145,061Feb 14, 2020, 03:48 PM
KING DAVID PDirectorFeb 12, 2020 Option Exercise$187.513,280615,033313,392Feb 14, 2020, 03:42 PM
BELINGARD JEAN-LUCDirectorFeb 12, 2020 Option Exercise$187.5112323,06438,061Feb 14, 2020, 03:30 PM
Williams R SandersDirectorFeb 13, 2020 Sale$188.491,227231,2775,095Feb 14, 2020, 03:08 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 07, 2020 Option Exercise$182.338214,951408Feb 11, 2020, 01:47 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 10, 2020 Sale$181.9910819,655300Feb 11, 2020, 01:47 PM
van der Vaart Sandra DSVP, Global General CounselFeb 07, 2020 Option Exercise$182.3310118,4152,662Feb 11, 2020, 01:45 PM
van der Vaart Sandra DSVP, Global General CounselFeb 10, 2020 Sale$181.9913324,2052,529Feb 11, 2020, 01:45 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 07, 2020 Option Exercise$182.3310318,7804,641Feb 11, 2020, 01:43 PM
KING DAVID PDirectorFeb 07, 2020 Option Exercise$182.331,252228,277308,923Feb 11, 2020, 01:42 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 07, 2020 Option Exercise$182.3329553,78717,758Feb 11, 2020, 01:39 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 07, 2020 Option Exercise$182.3310318,7806,291Feb 11, 2020, 01:38 PM
BELINGARD JEAN-LUCDirectorDec 04, 2019 Option Exercise$171.8232756,18536,957Dec 06, 2019, 03:07 PM
KING DAVID PPresident & CEOOct 28, 2019 Sale$165.4030,1774,991,216328,676Oct 30, 2019, 05:25 PM
ANDERSON KERRII BDirectorSep 23, 2019 Option Exercise$98.492,600256,07420,533Sep 25, 2019, 01:40 PM
ANDERSON KERRII BDirectorSep 23, 2019 Sale$171.852,600446,81017,933Sep 25, 2019, 01:40 PM
Uthgenannt Lisa JChief Human Resources OfficerSep 04, 2019 Option Exercise$130.602,466322,0607,126Sep 06, 2019, 09:54 AM
Uthgenannt Lisa JChief Human Resources OfficerSep 04, 2019 Sale$168.592,466415,7434,660Sep 06, 2019, 09:54 AM
BERBERIAN LANCESVP, Chief Information OfficerAug 30, 2019 Sale$169.805,9021,002,1716,097Sep 04, 2019, 09:04 AM
Williams R SandersDirectorAug 05, 2019 Sale$162.9150081,4556,886Aug 07, 2019, 11:40 AM
EISENBERG GLENN AChief Financial Officer, EVPJul 08, 2019 Sale$176.755,563983,26017,059Jul 10, 2019, 09:03 AM
van der Vaart Sandra DSVP, Global General CounselJul 08, 2019 Sale$176.752,328411,4742,328Jul 10, 2019, 09:02 AM
ANDERSON KERRII BDirectorJun 20, 2019 Option Exercise$77.193,100239,28922,233Jun 21, 2019, 03:26 PM
ANDERSON KERRII BDirectorJun 20, 2019 Sale$170.003,100527,00019,133Jun 21, 2019, 03:26 PM
EISENBERG GLENN AChief Financial Officer, EVPJun 07, 2019 Sale$167.4010,0001,673,97128,366Jun 11, 2019, 06:16 PM
Williams R SandersDirectorMay 06, 2019 Sale$162.2050081,1007,386May 08, 2019, 08:21 AM
MITTELSTAEDT ROBERT E JRDirectorMay 03, 2019 Option Exercise$64.423,700238,35418,909May 07, 2019, 11:00 AM
MITTELSTAEDT ROBERT E JRDirectorMay 03, 2019 Sale$166.303,700615,31015,209May 07, 2019, 11:00 AM
Uthgenannt Lisa JChief Human Resources OfficerMay 02, 2019 Sale$164.004,000656,0004,638May 06, 2019, 08:45 AM
Ratliff John DCEO, Covance Drug DevelopmentApr 03, 2019 Option Exercise$156.681,084169,84116,941Apr 05, 2019, 12:01 PM
KING DAVID PPresident & CEOApr 01, 2019 Option Exercise$154.7941,3116,394,529297,387Apr 03, 2019, 05:30 PM
EISENBERG GLENN AChief Financial Officer, EVPApr 01, 2019 Option Exercise$154.7910,0131,549,91232,622Apr 03, 2019, 05:29 PM
van der Vaart Sandra DSVP, Global General CounselApr 01, 2019 Option Exercise$154.791,782275,8364,656Apr 03, 2019, 05:27 PM
Dodson Edward TPrincipal Accounting OfficerApr 01, 2019 Option Exercise$154.791,779275,37113,663Apr 03, 2019, 05:24 PM
Uthgenannt Lisa JChief Human Resources OfficerApr 01, 2019 Option Exercise$154.793,236500,9008,638Apr 03, 2019, 05:20 PM
BERBERIAN LANCESVP, Chief Information OfficerApr 01, 2019 Option Exercise$154.792,287354,00511,999Apr 03, 2019, 05:18 PM
BELINGARD JEAN-LUCDirectorFeb 12, 2019 Option Exercise$146.5910415,24534,013Feb 14, 2019, 05:01 PM
BELINGARD JEAN-LUCDirectorFeb 12, 2019 Option Exercise$64.423,700238,35436,779Feb 14, 2019, 05:01 PM
BELINGARD JEAN-LUCDirectorFeb 12, 2019 Sale$146.063,700540,40733,079Feb 14, 2019, 05:01 PM
KING DAVID PPresident & CEOFeb 12, 2019 Option Exercise$146.591,571230,293246,281Feb 14, 2019, 04:44 PM
Williams R SandersDirectorFeb 13, 2019 Sale$147.001,038152,5867,886Feb 14, 2019, 04:18 PM
Dodson Edward TPrincipal Accounting OfficerFeb 12, 2019 Option Exercise$146.59547,9169,912Feb 14, 2019, 04:13 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 12, 2019 Option Exercise$146.59649,38228,823Feb 14, 2019, 04:10 PM
Ratliff John DCEO, Covance Drug DevelopmentFeb 12, 2019 Option Exercise$146.5965495,87015,601Feb 14, 2019, 04:08 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2019 Option Exercise$146.5923234,00920,235Feb 14, 2019, 04:05 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 12, 2019 Option Exercise$146.597010,2618,756Feb 14, 2019, 04:02 PM
Caveney Brian JSVP, Chief Medical OfficerFeb 12, 2019 Option Exercise$146.598212,020151Feb 14, 2019, 03:59 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 12, 2019 Option Exercise$146.5910315,0994,489Feb 14, 2019, 03:58 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 11, 2019 Option Exercise$144.2924034,6304,336Feb 13, 2019, 12:22 PM
Dodson Edward TPrincipal Accounting OfficerFeb 11, 2019 Option Exercise$144.2912417,8929,770Feb 13, 2019, 12:18 PM
KING DAVID PPresident & CEOFeb 11, 2019 Option Exercise$144.292,980429,984244,339Feb 13, 2019, 12:11 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 11, 2019 Option Exercise$144.2914320,63328,654Feb 13, 2019, 12:09 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 11, 2019 Option Exercise$144.291,449209,07619,687Feb 13, 2019, 12:05 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 11, 2019 Option Exercise$144.291,037149,6298,593Feb 13, 2019, 12:00 PM
Ratliff John DCEO, Covance Drug DevelopmentFeb 11, 2019 Option Exercise$144.291,973284,68414,792Feb 13, 2019, 11:55 AM
Ratliff John DCEO, Covance Drug DevelopmentFeb 07, 2019 Option Exercise$147.4655681,98810,665Feb 11, 2019, 07:59 PM
KING DAVID PPresident & CEOFeb 07, 2019 Option Exercise$147.461,254184,915239,775Feb 11, 2019, 07:56 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 07, 2019 Option Exercise$147.4629743,79616,259Feb 11, 2019, 07:53 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 07, 2019 Option Exercise$147.468212,09228,277Feb 11, 2019, 07:51 PM
Dodson Edward TPrincipal Accounting OfficerFeb 07, 2019 Option Exercise$147.466810,0279,444Feb 11, 2019, 07:48 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 07, 2019 Option Exercise$147.4614821,8243,972Feb 11, 2019, 07:46 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 07, 2019 Option Exercise$147.4610415,3366,133Feb 11, 2019, 07:44 PM
Williams R SandersDirectorNov 27, 2018 Sale$162.1435056,7497,886Nov 29, 2018, 10:00 AM
ANDERSON KERRII BDirectorNov 05, 2018 Option Exercise$64.423,700238,35421,795Nov 07, 2018, 10:54 AM
ANDERSON KERRII BDirectorNov 05, 2018 Sale$163.293,700604,16218,095Nov 07, 2018, 10:54 AM
Gary M. HuffCEO, LabCorp DiagnosticsSep 04, 2018 Option Exercise$169.156911,6711,850Sep 06, 2018, 10:21 AM
Dodson Edward TPrincipal Accounting OfficerJun 06, 2018 Option Exercise$84.8613,0001,103,18022,113Jun 08, 2018, 11:11 AM
Dodson Edward TPrincipal Accounting OfficerJun 06, 2018 Sale$183.3513,0002,383,5639,113Jun 08, 2018, 11:11 AM
Uthgenannt Lisa JChief Human Resources OfficerJun 04, 2018 Sale$182.104,500819,4503,755Jun 06, 2018, 02:59 PM
Gilliland Dwight GaryDirectorMay 31, 2018 Sale$181.291,263228,9674,637Jun 04, 2018, 04:17 PM
BERBERIAN LANCESVP, Chief Information OfficerMay 31, 2018 Sale$182.305,5001,002,6726,255Jun 04, 2018, 04:16 PM
Gary M. HuffCEO, LabCorp DiagnosticsMay 30, 2018 Sale$182.501,610293,8231,610Jun 01, 2018, 08:15 AM
EISENBERG GLENN AChief Financial Officer, EVPMay 30, 2018 Sale$181.2110,0001,812,06718,843Jun 01, 2018, 08:14 AM
KING DAVID PPresident & CEOMay 23, 2018 Option Exercise$84.8649,9664,240,115271,635May 25, 2018, 11:15 AM
KING DAVID PPresident & CEOMay 23, 2018 Sale$175.3749,9668,762,352227,069May 25, 2018, 11:15 AM
KING DAVID PPresident & CEOApr 23, 2018 Option Exercise$84.8649,9674,240,200271,636Apr 25, 2018, 04:59 PM
KING DAVID PPresident & CEOApr 23, 2018 Sale$166.1249,9678,300,692242,869Apr 25, 2018, 04:59 PM
Gary M. HuffCEO, LabCorp DiagnosticsApr 04, 2018 Option Exercise$163.841,376225,4443,220Apr 06, 2018, 09:39 AM
BERBERIAN LANCESVP, Chief Information OfficerMar 29, 2018 Option Exercise$161.752,121343,07211,440Apr 02, 2018, 11:54 AM
Dodson Edward TPrincipal Accounting OfficerMar 29, 2018 Option Exercise$161.751,600258,8009,113Apr 02, 2018, 11:53 AM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 29, 2018 Option Exercise$161.752,152348,08628,062Apr 02, 2018, 11:51 AM
EISENBERG GLENN AChief Financial Officer, EVPMar 29, 2018 Option Exercise$161.758,8501,431,48825,563Apr 02, 2018, 11:50 AM
KING DAVID PPresident & CEOMar 29, 2018 Option Exercise$161.7533,0155,340,176221,669Apr 02, 2018, 11:48 AM
Uthgenannt Lisa JChief Human Resources OfficerMar 29, 2018 Option Exercise$161.752,828457,4298,255Apr 02, 2018, 11:47 AM
KING DAVID PPresident & CEOMar 23, 2018 Option Exercise$84.8649,9674,240,200231,202Mar 27, 2018, 09:03 AM
KING DAVID PPresident & CEOMar 23, 2018 Sale$164.7549,9678,232,224229,513Mar 27, 2018, 09:03 AM
Dodson Edward TPrincipal Accounting OfficerMar 12, 2018 Option Exercise$175.6111119,4935,861Mar 14, 2018, 04:12 PM
KING DAVID PPresident & CEOMar 12, 2018 Option Exercise$175.612,732479,767181,235Mar 14, 2018, 03:47 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 12, 2018 Option Exercise$175.6112922,65424,619Mar 14, 2018, 03:38 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 12, 2018 Option Exercise$175.61732128,54714,726Mar 14, 2018, 03:33 PM
BERBERIAN LANCESVP, Chief Information OfficerMar 12, 2018 Option Exercise$175.6112021,0738,709Mar 14, 2018, 03:30 PM
Uthgenannt Lisa JChief Human Resources OfficerMar 12, 2018 Option Exercise$175.6118432,3124,590Mar 14, 2018, 03:28 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2018 Sale$167.368,4001,405,83915,931Feb 14, 2018, 02:32 PM
Ratliff John DCEO, Covance Drug DevelopmentFeb 09, 2018 Option Exercise$168.082,132358,3479,398Feb 13, 2018, 02:08 PM
ANDERSON KERRII BDirectorFeb 09, 2018 Option Exercise$75.633,300249,57921,395Feb 13, 2018, 01:58 PM
ANDERSON KERRII BDirectorFeb 09, 2018 Sale$166.103,300548,12318,095Feb 13, 2018, 01:58 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 09, 2018 Option Exercise$168.081,462245,73322,231Feb 13, 2018, 01:55 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 09, 2018 Option Exercise$168.081,048176,1488,429Feb 13, 2018, 01:54 PM
Dodson Edward TPrincipal Accounting OfficerFeb 09, 2018 Option Exercise$168.0816728,0695,506Feb 13, 2018, 01:51 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 09, 2018 Option Exercise$168.0814424,20424,284Feb 13, 2018, 01:47 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 09, 2018 Option Exercise$168.0820334,1204,237Feb 13, 2018, 01:46 PM
KING DAVID PPresident & CEOFeb 09, 2018 Option Exercise$168.083,138527,435177,890Feb 13, 2018, 01:44 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 07, 2018 Option Exercise$169.6612921,8863,837Feb 09, 2018, 04:16 PM
KING DAVID PPresident & CEOFeb 07, 2018 Option Exercise$169.661,264214,450173,485Feb 09, 2018, 04:13 PM
Ratliff John DCEO, Covance Drug DevelopmentFeb 07, 2018 Option Exercise$169.6656095,0105,430Feb 09, 2018, 04:11 PM
Gary M. HuffCEO, LabCorp DiagnosticsFeb 07, 2018 Option Exercise$169.6632955,8181,096Feb 09, 2018, 04:09 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 07, 2018 Option Exercise$169.6629950,72818,816Feb 09, 2018, 04:05 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 07, 2018 Option Exercise$169.668213,91223,908Feb 09, 2018, 04:02 PM
Dodson Edward TPrincipal Accounting OfficerFeb 07, 2018 Option Exercise$169.669215,6095,223Feb 09, 2018, 04:01 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 07, 2018 Option Exercise$169.6610517,8145,980Feb 09, 2018, 03:59 PM
Schechter Adam HDirectorFeb 08, 2018 Sale$169.291,263213,8136,034Feb 09, 2018, 03:56 PM
BELINGARD JEAN-LUCDirectorFeb 07, 2018 Option Exercise$169.6612721,54733,079Feb 09, 2018, 03:47 PM
Gilliland Dwight GaryDirectorOct 30, 2017 Sale$153.52971149,0683,501Nov 01, 2017, 10:31 AM
Gary M. HuffCEO, LabCorp DiagnosticsSep 01, 2017 Option Exercise$157.61518,038349Oct 23, 2017, 04:10 PM
KING DAVID PPresident & CEOSep 06, 2017 Option Exercise$90.7444,6874,054,898258,753Sep 07, 2017, 03:35 PM
KING DAVID PPresident & CEOSep 06, 2017 Sale$156.8644,6877,009,789221,566Sep 07, 2017, 03:35 PM
KING DAVID PPresident & CEOSep 05, 2017 Option Exercise$90.74132,71312,042,377346,779Sep 07, 2017, 09:18 AM
KING DAVID PPresident & CEOSep 05, 2017 Sale$157.06132,71320,843,373214,066Sep 07, 2017, 09:18 AM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryAug 25, 2017 Option Exercise$69.1231,5002,177,23955,194Aug 29, 2017, 02:26 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryAug 25, 2017 Sale$155.2231,5004,889,46123,694Aug 29, 2017, 02:26 PM
Williams R SandersDirectorAug 11, 2017 Option Exercise$77.193,100239,28910,073Aug 15, 2017, 03:03 PM
Williams R SandersDirectorAug 11, 2017 Sale$156.883,100486,3389,873Aug 15, 2017, 03:03 PM
Dodson Edward TPrincipal Accounting OfficerAug 01, 2017 Sale$160.132,871459,7407,702Aug 03, 2017, 04:35 PM
Uthgenannt Lisa JChief Human Resources OfficerAug 01, 2017 Sale$160.005,000800,0003,622Aug 03, 2017, 04:29 PM
EISENBERG GLENN AChief Financial Officer, EVPAug 01, 2017 Sale$159.465,968951,66918,122Aug 03, 2017, 04:22 PM
EISENBERG GLENN AChief Financial Officer, EVPJun 16, 2017 Option Exercise$140.771,926271,12324,090Jun 19, 2017, 02:48 PM
BERBERIAN LANCESVP, Chief Information OfficerMay 22, 2017 Sale$139.853,613505,2605,789May 24, 2017, 11:25 AM
BELINGARD JEAN-LUCDirectorMay 09, 2017 Option Exercise$77.5899276,95932,935May 11, 2017, 08:17 AM
BELINGARD JEAN-LUCDirectorMay 09, 2017 Sale$142.19992141,05231,943May 11, 2017, 08:17 AM
BERBERIAN LANCESVP, Chief Information OfficerMar 29, 2017 Option Exercise$143.193,142449,9039,402Mar 31, 2017, 01:50 PM
Dodson Edward TPrincipal Accounting OfficerMar 29, 2017 Option Exercise$143.192,850408,0927,754Mar 31, 2017, 01:49 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 29, 2017 Option Exercise$143.193,212459,92623,694Mar 31, 2017, 01:48 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 29, 2017 Option Exercise$143.199,7531,396,53221,966Mar 31, 2017, 01:47 PM
KING DAVID PPresident & CEOMar 29, 2017 Option Exercise$143.1948,5966,958,461198,359Mar 31, 2017, 01:45 PM
Uthgenannt Lisa JChief Human Resources OfficerMar 13, 2017 Option Exercise$144.243,654527,0538,803Mar 14, 2017, 03:17 PM
BERBERIAN LANCESVP, Chief Information OfficerMar 13, 2017 Option Exercise$144.2413219,0405,789Mar 14, 2017, 02:52 PM
Dodson Edward TPrincipal Accounting OfficerMar 13, 2017 Option Exercise$144.2414921,4923,849Mar 14, 2017, 02:44 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 13, 2017 Option Exercise$144.2415322,06919,136Mar 14, 2017, 02:43 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 13, 2017 Option Exercise$144.24774111,64211,209Mar 14, 2017, 02:41 PM
KING DAVID PPresident & CEOMar 13, 2017 Option Exercise$144.242,890416,854144,755Mar 14, 2017, 02:39 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 09, 2017 Sale$142.472,300327,69112,556Mar 13, 2017, 09:34 AM
MITTELSTAEDT ROBERT E JRDirectorFeb 24, 2017 Option Exercise$75.635,300400,83918,208Feb 27, 2017, 02:40 PM
MITTELSTAEDT ROBERT E JRDirectorFeb 24, 2017 Sale$142.695,300756,25618,008Feb 27, 2017, 02:40 PM
ANDERSON KERRII BDirectorFeb 24, 2017 Option Exercise$75.631,00075,63016,832Feb 27, 2017, 02:39 PM
ANDERSON KERRII BDirectorFeb 23, 2017 Option Exercise$76.601,992152,58916,832Feb 27, 2017, 02:39 PM
ANDERSON KERRII BDirectorFeb 23, 2017 Sale$140.001,992278,88015,832Feb 27, 2017, 02:39 PM
Dodson Edward TPrincipal Accounting OfficerFeb 13, 2017 Option Exercise$134.9318224,5573,598Feb 14, 2017, 05:45 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 13, 2017 Option Exercise$134.9320627,79618,826Feb 14, 2017, 05:45 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 13, 2017 Option Exercise$134.9355274,48112,656Feb 14, 2017, 05:42 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 13, 2017 Option Exercise$134.9348965,9815,703Feb 14, 2017, 05:42 PM
KING DAVID PPresident & CEOFeb 13, 2017 Option Exercise$134.933,968535,402141,568Feb 14, 2017, 05:42 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 13, 2017 Option Exercise$134.9348965,9815,703Feb 14, 2017, 05:40 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 09, 2017 Option Exercise$133.8324432,6554,039Feb 13, 2017, 02:40 PM
Dodson Edward TPrincipal Accounting OfficerFeb 09, 2017 Option Exercise$133.8313818,4693,230Feb 13, 2017, 02:31 PM
Ratliff John DCEO, Covance Drug DevelopmentFeb 09, 2017 Option Exercise$133.832,013269,4004,127Feb 13, 2017, 02:28 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 09, 2017 Option Exercise$133.8318825,16018,398Feb 13, 2017, 02:26 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 09, 2017 Option Exercise$133.831,610215,46611,534Feb 13, 2017, 02:24 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 09, 2017 Option Exercise$133.831,171156,7154,530Feb 13, 2017, 02:23 PM
KING DAVID PPresident & CEOFeb 09, 2017 Option Exercise$133.832,496334,040137,192Feb 13, 2017, 02:21 PM
BELINGARD JEAN-LUCDirectorFeb 09, 2017 Option Exercise$133.8315620,87731,943Feb 13, 2017, 01:53 PM
Uthgenannt Lisa JChief Human Resources OfficerAug 09, 2016 Sale$140.001,177164,7803,660Aug 11, 2016, 07:57 AM
EISENBERG GLENN AChief Financial Officer, EVPAug 04, 2016 Sale$140.108,0001,120,8048,668Aug 08, 2016, 02:58 PM
MITTELSTAEDT ROBERT E JRDirectorAug 04, 2016 Option Exercise$77.5899276,95912,340Aug 08, 2016, 02:55 PM
MITTELSTAEDT ROBERT E JRDirectorAug 04, 2016 Sale$140.15992139,02711,348Aug 08, 2016, 02:55 PM
EISENBERG GLENN AChief Financial Officer, EVPJun 16, 2016 Option Exercise$127.351,936246,55016,268Jun 20, 2016, 10:38 AM
KING DAVID PPresident & CEOJun 13, 2016 Option Exercise$70.15196,40013,777,460271,210Jun 15, 2016, 04:03 PM
KING DAVID PPresident & CEOJun 13, 2016 Sale$128.00196,40025,139,088197,755Jun 15, 2016, 04:03 PM
Uthgenannt Lisa JChief Human Resources OfficerApr 29, 2016 Sale$125.173,740468,1364,837May 13, 2016, 04:03 PM
Dodson Edward TPrincipal Accounting OfficerApr 27, 2016 Sale$126.429,3921,187,3372,717Apr 29, 2016, 09:01 AM
KING DAVID PPresident & CEOMar 30, 2016 Option Exercise$117.8548,4255,706,886147,371Apr 01, 2016, 01:22 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 30, 2016 Option Exercise$117.856,007707,92514,154Apr 01, 2016, 01:21 PM
Dodson Edward TPrincipal Accounting OfficerMar 30, 2016 Option Exercise$117.852,349276,83012,109Apr 01, 2016, 01:15 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 30, 2016 Option Exercise$117.852,466290,61822,285Apr 01, 2016, 01:12 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 31, 2016 Sale$116.854,219492,99018,066Apr 01, 2016, 01:12 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsMar 30, 2016 Option Exercise$117.8516,6051,956,89941,586Apr 01, 2016, 01:11 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsMar 31, 2016 Sale$116.8118,1322,118,03028,395Apr 01, 2016, 01:11 PM
BELINGARD JEAN-LUCDirectorMar 11, 2016 Option Exercise$115.4912414,32130,539Mar 15, 2016, 03:35 PM
BERBERIAN LANCESVP, Chief Information OfficerMar 11, 2016 Option Exercise$115.4913315,3602,205Mar 15, 2016, 01:45 PM
Dodson Edward TPrincipal Accounting OfficerMar 11, 2016 Option Exercise$115.4912414,3217,773Mar 15, 2016, 01:44 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 11, 2016 Option Exercise$115.4977889,8517,596Mar 15, 2016, 01:42 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 11, 2016 Option Exercise$115.4915417,78518,375Mar 15, 2016, 01:41 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 14, 2016 Sale$115.3230935,63418,066Mar 15, 2016, 01:41 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsMar 11, 2016 Option Exercise$115.491,413163,18724,997Mar 15, 2016, 01:39 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsMar 14, 2016 Sale$115.321,543177,93923,454Mar 15, 2016, 01:39 PM
KING DAVID PPresident & CEOMar 11, 2016 Option Exercise$115.492,905335,49894,489Mar 15, 2016, 01:37 PM
Keller Deborah LCEO, Covance Drug DevelopmentMar 11, 2016 Option Exercise$115.494,587529,75319,754Mar 15, 2016, 01:36 PM
Uthgenannt Lisa JChief Human Resources OfficerMar 11, 2016 Option Exercise$115.493,379390,2418,577Mar 15, 2016, 01:34 PM
BELINGARD JEAN-LUCDirectorFeb 25, 2016 Option Exercise$59.371,29676,94430,722Feb 29, 2016, 01:52 PM
BELINGARD JEAN-LUCDirectorFeb 25, 2016 Sale$109.741,296142,22530,504Feb 29, 2016, 01:52 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsFeb 16, 2016 Sale$103.024,055417,74625,614Feb 18, 2016, 08:28 AM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 16, 2016 Sale$103.0237038,11718,066Feb 18, 2016, 08:27 AM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsFeb 11, 2016 Option Exercise$101.401,345136,38326,166Feb 16, 2016, 04:30 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsFeb 12, 2016 Option Exercise$103.022,116217,99027,509Feb 16, 2016, 04:30 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsFeb 12, 2016 Sale$101.672,712275,72923,454Feb 16, 2016, 04:30 PM
KING DAVID PPresident & CEOFeb 12, 2016 Option Exercise$103.023,735384,78091,318Feb 16, 2016, 04:25 PM
KING DAVID PPresident & CEOFeb 11, 2016 Option Exercise$101.402,768280,67586,783Feb 16, 2016, 04:25 PM
Dodson Edward TPrincipal Accounting OfficerFeb 12, 2016 Option Exercise$103.0218218,7507,497Feb 16, 2016, 04:24 PM
Dodson Edward TPrincipal Accounting OfficerFeb 11, 2016 Option Exercise$101.4021221,4977,132Feb 16, 2016, 04:24 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 11, 2016 Option Exercise$101.4055556,2775,720Feb 16, 2016, 04:23 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2016 Option Exercise$103.0251252,7466,748Feb 16, 2016, 04:23 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 11, 2016 Option Exercise$101.4051352,0181,938Feb 16, 2016, 04:22 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 12, 2016 Option Exercise$103.0217718,23518,436Feb 16, 2016, 04:21 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 11, 2016 Option Exercise$101.4022823,11918,471Feb 16, 2016, 04:21 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 12, 2016 Sale$101.6740541,17618,066Feb 16, 2016, 04:21 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryJan 08, 2016 Sale$119.051,215144,64618,066Jan 12, 2016, 04:51 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryDec 08, 2015 Sale$123.311,010124,54319,281Dec 10, 2015, 04:38 PM
Williams R SandersDirectorNov 02, 2015 Option Exercise$64.421,850119,1776,026Nov 04, 2015, 03:20 PM
Williams R SandersDirectorNov 02, 2015 Sale$124.301,850229,9495,076Nov 04, 2015, 03:20 PM
ANDERSON KERRII BDirectorOct 29, 2015 Option Exercise$59.371,29676,94413,035Nov 02, 2015, 02:31 PM
KING DAVID PPresident & CEOAug 03, 2015 Option Exercise$80.3750,0004,018,500131,153Aug 05, 2015, 03:53 PM
KING DAVID PPresident & CEOAug 03, 2015 Sale$127.9350,0006,396,35897,453Aug 05, 2015, 03:53 PM
HERRING JOSEPH LCEO of Covance Drug DivisionJul 31, 2015 Option Exercise$127.299,5861,220,20210,404Aug 04, 2015, 02:15 PM
KING DAVID PPresident & CEOJul 01, 2015 Option Exercise$80.3750,0004,018,500116,063Jul 06, 2015, 09:08 PM
KING DAVID PPresident & CEOJul 01, 2015 Sale$121.7850,0006,089,04095,553Jul 06, 2015, 09:08 PM
EISENBERG GLENN AChief Financial Officer, EVPJun 16, 2015 Option Exercise$120.481,596192,2864,602Jun 18, 2015, 04:07 PM
KING DAVID PPresident & CEOJun 01, 2015 Option Exercise$80.3750,0004,018,500115,899Jun 03, 2015, 04:17 PM
KING DAVID PPresident & CEOJun 01, 2015 Sale$118.5850,0005,928,845114,990Jun 03, 2015, 04:17 PM
MITTELSTAEDT ROBERT E JRDirectorMay 19, 2015 Option Exercise$59.371,29676,94411,407May 21, 2015, 01:30 PM
MITTELSTAEDT ROBERT E JRDirectorMay 19, 2015 Sale$119.021,296154,25411,007May 21, 2015, 01:30 PM
Williams R SandersDirectorMay 11, 2015 Sale$118.05965113,9144,678May 14, 2015, 10:58 AM
BELINGARD JEAN-LUCDirectorApr 29, 2015 Option Exercise$49.931,54276,99230,968May 01, 2015, 05:14 PM
BELINGARD JEAN-LUCDirectorApr 29, 2015 Sale$123.101,542189,82029,426May 01, 2015, 05:14 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsApr 23, 2015 Sale$126.561,394176,42524,648Apr 27, 2015, 05:28 PM
Brecher Mark ECMO, LabCorp DiagnosticsMar 30, 2015 Option Exercise$127.2817221,8926,936Apr 01, 2015, 08:35 PM
Brecher Mark ECMO, LabCorp DiagnosticsMar 30, 2015 Option Exercise$88.4119,2001,697,52026,136Apr 01, 2015, 08:35 PM
Brecher Mark ECMO, LabCorp DiagnosticsMar 31, 2015 Sale$127.0034744,0695,511Apr 01, 2015, 08:35 PM
Brecher Mark ECMO, LabCorp DiagnosticsMar 30, 2015 Sale$126.9820,2782,574,9215,858Apr 01, 2015, 08:35 PM
KING DAVID PPresident & CEOMar 30, 2015 Option Exercise$127.283,974505,81165,899Apr 01, 2015, 07:50 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsMar 30, 2015 Option Exercise$127.281,272161,90024,848Apr 01, 2015, 07:48 PM
Dodson Edward TPrincipal Accounting OfficerMar 30, 2015 Option Exercise$127.2817221,8926,575Apr 01, 2015, 07:46 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 30, 2015 Option Exercise$127.2817221,89220,291Apr 01, 2015, 07:44 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 02, 2015 Option Exercise$123.361,130139,39724,691Mar 04, 2015, 10:38 AM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 03, 2015 Sale$123.701,237153,01524,654Mar 04, 2015, 10:38 AM
Dodson Edward TPrincipal Accounting OfficerMar 02, 2015 Option Exercise$123.3615418,9976,228Mar 04, 2015, 10:37 AM
Brecher Mark EChief Medical OfficerMar 02, 2015 Option Exercise$123.3615418,9976,589Mar 04, 2015, 10:36 AM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 02, 2015 Option Exercise$123.3615519,12119,944Mar 04, 2015, 10:35 AM
KING DAVID PPresident & CEOMar 02, 2015 Option Exercise$123.363,515433,61061,543Mar 04, 2015, 10:33 AM
Williams R SandersDirectorFeb 26, 2015 Sale$123.962,267281,0256,441Mar 02, 2015, 04:26 PM
HERRING JOSEPH LCEO of Covance Drug DivisionFeb 25, 2015 Sale$121.6436,8764,485,4366,158Feb 27, 2015, 06:32 PM
Dodson Edward TPrincipal Accounting OfficerFeb 12, 2015 Option Exercise$116.8417820,7986,382Feb 17, 2015, 04:06 PM
KING DAVID PPresident & CEOFeb 12, 2015 Option Exercise$116.843,945460,93465,058Feb 17, 2015, 04:05 PM
Brecher Mark EChief Medical OfficerFeb 12, 2015 Option Exercise$116.8417720,6816,743Feb 17, 2015, 04:01 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 12, 2015 Option Exercise$116.8417820,79820,099Feb 17, 2015, 03:58 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2015 Option Exercise$116.8451059,5882,148Feb 17, 2015, 03:57 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 12, 2015 Option Exercise$116.842,287267,21329,704Feb 17, 2015, 03:55 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 13, 2015 Sale$116.663,883452,99127,807Feb 17, 2015, 03:55 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 12, 2015 Sale$116.712,714316,75125,821Feb 17, 2015, 03:55 PM
Dodson Edward TPrincipal Accounting OfficerFeb 11, 2015 Option Exercise$116.7321224,7476,013Feb 13, 2015, 05:44 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 11, 2015 Option Exercise$116.731,342156,65228,535Feb 13, 2015, 05:10 PM
Brecher Mark EChief Medical OfficerFeb 11, 2015 Option Exercise$116.7321324,8636,373Feb 13, 2015, 04:54 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 11, 2015 Option Exercise$116.7322826,61419,730Feb 13, 2015, 04:44 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 11, 2015 Option Exercise$116.7355564,7851,118Feb 13, 2015, 04:40 PM
KING DAVID PPresident & CEOFeb 11, 2015 Option Exercise$116.733,262380,77360,733Feb 13, 2015, 04:39 PM
BELINGARD JEAN-LUCDirectorFeb 10, 2015 Option Exercise$115.3915117,42429,426Feb 12, 2015, 04:07 PM
KING DAVID PPresident & CEOSep 22, 2014 Option Exercise$75.6365,2344,933,647120,817Sep 24, 2014, 11:44 AM
KING DAVID PPresident & CEOSep 22, 2014 Sale$104.7165,2346,830,74160,283Sep 24, 2014, 11:44 AM
Williams R SandersDirectorSep 05, 2014 Sale$107.952,000215,9066,505Sep 09, 2014, 03:35 PM
KING DAVID PPresident & CEOAug 22, 2014 Option Exercise$75.6365,2334,933,572120,816Aug 26, 2014, 02:38 PM
KING DAVID PPresident & CEOAug 22, 2014 Sale$106.1065,2336,921,48255,583Aug 26, 2014, 02:38 PM
KING DAVID PPresident & CEOJul 22, 2014 Option Exercise$75.6365,2334,933,572120,816Jul 24, 2014, 04:43 PM
KING DAVID PPresident & CEOJul 22, 2014 Sale$105.5565,2336,885,41157,183Jul 24, 2014, 04:43 PM
Boyle James T. Jr.EVP, Chief Operating OfficerJun 09, 2014 Option Exercise$84.8638,6003,275,59664,421Jun 10, 2014, 04:25 PM
Boyle James T. Jr.EVP, Chief Operating OfficerJun 09, 2014 Sale$103.0038,6003,975,80025,821Jun 10, 2014, 04:25 PM
Hayes William BChief Financial Officer, EVPJun 06, 2014 Option Exercise$88.3647,3674,185,38066,767Jun 10, 2014, 04:24 PM
Hayes William BChief Financial Officer, EVPJun 06, 2014 Sale$104.2347,3674,936,96541,500Jun 10, 2014, 04:24 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryJun 06, 2014 Option Exercise$60.0410,000600,40029,325Jun 10, 2014, 04:12 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryJun 06, 2014 Sale$104.3710,0001,043,70019,325Jun 10, 2014, 04:12 PM
Brecher Mark EChief Medical OfficerJun 04, 2014 Sale$102.312,600266,0065,754Jun 06, 2014, 02:53 PM
Williams R SandersDirectorMay 08, 2014 Option Exercise$98.961,593157,6437,905May 12, 2014, 05:11 PM
Rubenstein Arthur HDirectorMay 08, 2014 Option Exercise$98.961,593157,64311,772May 12, 2014, 05:10 PM
Schechter Adam HDirectorMay 08, 2014 Option Exercise$98.961,593157,6431,734May 12, 2014, 05:07 PM
NEUPERT PETER MDirectorMay 08, 2014 Option Exercise$98.961,593157,6432,168May 12, 2014, 05:05 PM
MITTELSTAEDT ROBERT E JRDirectorMay 08, 2014 Option Exercise$98.961,593157,6438,608May 12, 2014, 05:04 PM
LANE WENDY EDirectorMay 08, 2014 Option Exercise$98.961,593157,64318,988May 12, 2014, 05:03 PM
BELINGARD JEAN-LUCDirectorMay 08, 2014 Option Exercise$98.9616015,83428,074May 12, 2014, 05:00 PM
BELINGARD JEAN-LUCDirectorMay 08, 2014 Option Exercise$98.961,593157,64328,234May 12, 2014, 05:00 PM
ANDERSON KERRII BDirectorMay 08, 2014 Option Exercise$98.961,593157,64310,236May 12, 2014, 04:56 PM
WEIKEL M KEITHDirectorMay 08, 2014 Option Exercise$98.961,593157,64313,958May 09, 2014, 03:35 PM
WEIKEL M KEITHDirectorMay 07, 2014 Option Exercise$38.801,98476,97914,349May 09, 2014, 03:35 PM
WEIKEL M KEITHDirectorMay 07, 2014 Sale$98.281,984194,97913,248May 09, 2014, 03:35 PM
BELINGARD JEAN-LUCDirectorApr 30, 2014 Option Exercise$38.801,98476,97928,625May 02, 2014, 05:13 PM
BELINGARD JEAN-LUCDirectorApr 30, 2014 Sale$98.681,984195,78228,525May 02, 2014, 05:13 PM
Hayes William BChief Financial Officer, EVPApr 30, 2014 Sale$98.392,497245,68019,400May 02, 2014, 05:12 PM
LANE WENDY EDirectorApr 30, 2014 Option Exercise$38.8099238,49017,785May 02, 2014, 05:11 PM
LANE WENDY EDirectorApr 30, 2014 Sale$98.9739038,59917,395May 02, 2014, 05:11 PM
MITTELSTAEDT ROBERT E JRDirectorApr 30, 2014 Option Exercise$43.673,526153,9718,999May 02, 2014, 05:10 PM
MITTELSTAEDT ROBERT E JRDirectorApr 30, 2014 Sale$98.393,526346,9237,015May 02, 2014, 05:10 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 27, 2014 Option Exercise$97.872,304225,49228,342Mar 31, 2014, 03:55 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 28, 2014 Sale$98.362,521247,96625,821Mar 31, 2014, 03:55 PM
Brecher Mark EChief Medical OfficerMar 27, 2014 Option Exercise$97.8732932,1998,354Mar 31, 2014, 03:53 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 27, 2014 Option Exercise$97.8732932,19919,325Mar 31, 2014, 03:52 PM
Hayes William BChief Financial Officer, EVPMar 27, 2014 Option Exercise$97.872,283223,43721,897Mar 31, 2014, 03:51 PM
KING DAVID PPresident & CEOMar 27, 2014 Option Exercise$97.877,193703,97970,147Mar 31, 2014, 03:50 PM
Hayes William BChief Financial Officer, EVPMar 07, 2014 Option Exercise$84.8619,1661,626,42738,566Mar 10, 2014, 08:57 AM
Hayes William BChief Financial Officer, EVPMar 06, 2014 Sale$94.004,682440,11923,802Mar 10, 2014, 08:57 AM
Hayes William BChief Financial Officer, EVPMar 07, 2014 Sale$94.5019,1661,811,18719,400Mar 10, 2014, 08:57 AM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 03, 2014 Sale$93.061,582147,22125,821Mar 10, 2014, 08:54 AM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 28, 2014 Option Exercise$93.5478573,42927,403Mar 04, 2014, 02:00 PM
Brecher Mark EChief Medical OfficerFeb 28, 2014 Option Exercise$93.5415114,1257,691Mar 04, 2014, 01:58 PM
Hayes William BChief Financial Officer, EVPFeb 28, 2014 Option Exercise$93.5477472,40024,082Mar 04, 2014, 01:57 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 28, 2014 Option Exercise$93.5415114,12518,662Mar 04, 2014, 01:55 PM
KING DAVID PPresident & CEOFeb 28, 2014 Option Exercise$93.543,518329,07462,277Mar 04, 2014, 01:53 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 12, 2014 Option Exercise$90.982,046186,14532,311Feb 14, 2014, 07:29 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 13, 2014 Sale$90.294,123372,26630,416Feb 14, 2014, 07:29 PM
KING DAVID PPresident & CEOFeb 12, 2014 Option Exercise$90.983,949359,28065,795Feb 13, 2014, 07:39 PM
Brecher Mark EChief Medical OfficerFeb 12, 2014 Option Exercise$90.9819417,6507,842Feb 13, 2014, 07:36 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 12, 2014 Option Exercise$90.9818416,74018,813Feb 13, 2014, 07:34 PM
Hayes William BChief Financial Officer, EVPFeb 12, 2014 Option Exercise$90.9893484,97524,856Feb 13, 2014, 07:30 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 10, 2014 Option Exercise$91.3514212,97218,451Feb 12, 2014, 03:40 PM
Brecher Mark EChief Medical OfficerFeb 10, 2014 Option Exercise$91.3514212,9727,490Feb 12, 2014, 03:30 PM
Hayes William BChief Financial Officer, EVPFeb 10, 2014 Option Exercise$91.3560054,81022,974Feb 12, 2014, 03:28 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 10, 2014 Option Exercise$91.3559654,44529,392Feb 12, 2014, 03:27 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 11, 2014 Sale$91.151,204109,74528,188Feb 12, 2014, 03:27 PM
KING DAVID PPresident & CEOFeb 10, 2014 Option Exercise$91.352,225203,25461,474Feb 12, 2014, 03:22 PM
KING DAVID PPresident & CEOJan 27, 2014 Option Exercise$60.0424,2001,452,96887,899Jan 29, 2014, 03:18 PM
KING DAVID PPresident & CEOJan 27, 2014 Sale$90.1524,2002,181,63763,699Jan 29, 2014, 03:18 PM
KING DAVID PPresident & CEODec 24, 2013 Option Exercise$60.0425,0001,501,00088,628Dec 27, 2013, 04:50 PM
KING DAVID PPresident & CEODec 24, 2013 Sale$90.7925,0002,269,75063,628Dec 27, 2013, 04:50 PM
Brecher Mark EChief Medical OfficerNov 25, 2013 Sale$105.6240042,2487,585Nov 27, 2013, 10:59 AM
KING DAVID PPresident & CEONov 25, 2013 Option Exercise$60.0425,0001,501,00088,628Nov 27, 2013, 09:55 AM
KING DAVID PPresident & CEONov 25, 2013 Sale$106.0125,0002,650,30063,628Nov 27, 2013, 09:55 AM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryNov 11, 2013 Option Exercise$58.5710,000585,70028,593Nov 13, 2013, 01:54 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryNov 11, 2013 Sale$105.8310,0001,058,35018,593Nov 13, 2013, 01:54 PM
KING DAVID PPresident & CEOOct 24, 2013 Option Exercise$60.0425,0001,501,00088,628Oct 28, 2013, 09:14 AM
KING DAVID PPresident & CEOOct 24, 2013 Sale$100.9125,0002,522,80168,041Oct 28, 2013, 09:14 AM
Boyle James T. Jr.EVP, Chief Operating OfficerOct 17, 2013 Option Exercise$77.5724,4001,892,77244,388Oct 21, 2013, 02:59 PM
Boyle James T. Jr.EVP, Chief Operating OfficerOct 17, 2013 Sale$102.0024,4002,488,80029,988Oct 21, 2013, 02:59 PM
KING DAVID PPresident & CEOSep 25, 2013 Option Exercise$60.0425,0001,501,00088,628Sep 27, 2013, 10:45 AM
KING DAVID PPresident & CEOSep 25, 2013 Sale$99.0625,0002,476,61563,628Sep 27, 2013, 10:45 AM
KING DAVID PPresident & CEOAug 26, 2013 Option Exercise$60.0425,0001,501,00088,628Aug 28, 2013, 12:01 PM
KING DAVID PPresident & CEOAug 26, 2013 Sale$96.6025,0002,415,04763,628Aug 28, 2013, 12:01 PM
MITTELSTAEDT ROBERT E JRDirectorAug 21, 2013 Sale$96.867,429719,59214,244Aug 23, 2013, 10:09 AM
KING DAVID PPresident & CEOJul 24, 2013 Option Exercise$60.0425,0001,501,00088,628Jul 26, 2013, 03:56 PM
KING DAVID PPresident & CEOJul 24, 2013 Sale$97.7225,0002,442,89763,628Jul 26, 2013, 03:56 PM
KING DAVID PPresident & CEOJun 24, 2013 Option Exercise$60.0425,0001,501,00088,423Jun 26, 2013, 05:38 PM
KING DAVID PPresident & CEOJun 24, 2013 Sale$98.6625,0002,466,53364,123Jun 26, 2013, 05:38 PM
Boyle James T. Jr.EVP, Chief Operating OfficerJun 07, 2013 Option Exercise$70.1563,1004,426,46593,088Jun 11, 2013, 02:19 PM
Boyle James T. Jr.EVP, Chief Operating OfficerJun 07, 2013 Sale$99.6363,1006,286,65329,988Jun 11, 2013, 02:19 PM
Brecher Mark EChief Medical OfficerMay 28, 2013 Option Exercise$70.1514,9001,045,23524,653May 30, 2013, 04:34 PM
Brecher Mark EChief Medical OfficerMay 28, 2013 Sale$100.9216,9001,705,5487,753May 30, 2013, 04:34 PM
BELINGARD JEAN-LUCDirectorMay 24, 2013 Option Exercise$100.37606,02226,641May 29, 2013, 04:35 PM
Hayes William BChief Financial Officer, EVPMay 21, 2013 Option Exercise$77.68127,2009,880,83695,774May 23, 2013, 04:05 PM
Hayes William BChief Financial Officer, EVPMay 21, 2013 Sale$100.00127,20012,720,00023,574May 23, 2013, 04:05 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMay 17, 2013 Option Exercise$47.8910,000478,90028,593May 21, 2013, 05:26 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMay 17, 2013 Sale$98.4710,000984,70018,593May 21, 2013, 05:26 PM
BELINGARD JEAN-LUCDirectorMay 13, 2013 Option Exercise$95.01545,13126,701May 15, 2013, 05:03 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMay 10, 2013 Option Exercise$59.1360,7343,591,26198,896May 14, 2013, 04:37 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMay 10, 2013 Sale$93.8268,9086,464,86629,988May 14, 2013, 04:37 PM
BELINGARD JEAN-LUCDirectorMay 08, 2013 Option Exercise$30.362,53676,99329,291May 10, 2013, 07:56 AM
BELINGARD JEAN-LUCDirectorMay 08, 2013 Sale$92.882,536235,54426,755May 10, 2013, 07:56 AM
WEIKEL M KEITHDirectorMay 03, 2013 Option Exercise$31.352,04664,14214,411May 06, 2013, 12:35 PM
WEIKEL M KEITHDirectorMay 03, 2013 Sale$92.912,046190,08612,965May 06, 2013, 12:35 PM
LANE WENDY EDirectorApr 29, 2013 Option Exercise$93.7341238,61716,831May 01, 2013, 03:37 PM
LANE WENDY EDirectorApr 29, 2013 Option Exercise$30.361,26838,49617,205May 01, 2013, 03:37 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryApr 25, 2013 Sale$93.841,500140,76018,593Apr 29, 2013, 03:49 PM
Williams R SandersDirectorApr 24, 2013 Option Exercise$64.421,850119,1778,162Apr 25, 2013, 01:13 PM
Williams R SandersDirectorApr 24, 2013 Sale$93.771,850173,4776,932Apr 25, 2013, 01:13 PM
Hayes William BChief Financial Officer, EVPApr 11, 2013 Option Exercise$70.1522,2341,559,71545,808Apr 15, 2013, 03:37 PM
Hayes William BChief Financial Officer, EVPApr 11, 2013 Sale$95.0022,2342,112,23023,574Apr 15, 2013, 03:37 PM
KING DAVID PPresident & CEOMar 28, 2013 Option Exercise$90.2017,1801,549,63663,423Apr 01, 2013, 03:47 PM
Fonseca LidiaChief Information OfficerMar 28, 2013 Option Exercise$90.2087278,6549,087Apr 01, 2013, 03:45 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 28, 2013 Option Exercise$90.2087278,65420,093Apr 01, 2013, 03:44 PM
Hayes William BChief Financial Officer, EVPMar 28, 2013 Option Exercise$90.205,580503,31628,523Apr 01, 2013, 03:43 PM
Brecher Mark EChief Medical OfficerMar 28, 2013 Option Exercise$90.2090381,4519,753Apr 01, 2013, 03:41 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 28, 2013 Option Exercise$90.205,484494,65738,162Apr 01, 2013, 03:32 PM
KING DAVID PPresident & CEOFeb 28, 2013 Option Exercise$88.603,533313,02444,776Mar 04, 2013, 02:32 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 28, 2013 Option Exercise$88.6079069,99432,171Mar 04, 2013, 02:30 PM
Hayes William BChief Financial Officer, EVPFeb 28, 2013 Option Exercise$88.6077969,01921,974Mar 04, 2013, 02:29 PM
Brecher Mark EChief Medical OfficerFeb 28, 2013 Option Exercise$88.6015613,8227,951Mar 04, 2013, 02:27 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 28, 2013 Option Exercise$88.6015613,82218,353Mar 04, 2013, 02:26 PM
Fonseca LidiaChief Information OfficerFeb 28, 2013 Option Exercise$88.6015613,8227,347Mar 04, 2013, 02:24 PM
KING DAVID PPresident & CEOFeb 11, 2013 Option Exercise$90.064,115370,59750,292Feb 13, 2013, 05:17 PM
Brecher Mark EChief Medical OfficerFeb 11, 2013 Option Exercise$90.0632228,9998,235Feb 13, 2013, 05:15 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 11, 2013 Option Exercise$90.0631027,91918,638Feb 13, 2013, 05:10 PM
Fonseca LidiaChief Information OfficerFeb 11, 2013 Option Exercise$90.0631027,9197,632Feb 13, 2013, 05:06 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 11, 2013 Option Exercise$90.061,298116,89833,562Feb 13, 2013, 05:04 PM
Hayes William BChief Financial Officer, EVPFeb 11, 2013 Option Exercise$90.061,325119,32923,343Feb 13, 2013, 05:03 PM
MAC MAHON THOMAS PDirectorSep 06, 2012 Sale$89.7435,0003,141,04432,297Sep 10, 2012, 11:10 AM
MITTELSTAEDT ROBERT E JRDirectorAug 27, 2012 Option Exercise$30.362,53676,99316,980Aug 29, 2012, 03:01 PM
MITTELSTAEDT ROBERT E JRDirectorAug 27, 2012 Sale$88.612,536224,71514,444Aug 29, 2012, 03:01 PM
Brecher Mark EChief Medical OfficerJul 13, 2012 Option Exercise$60.0419,2001,152,76828,716Jul 17, 2012, 03:05 PM
Brecher Mark EChief Medical OfficerJul 13, 2012 Sale$95.0020,3411,932,3959,516Jul 17, 2012, 03:05 PM
Fonseca LidiaChief Information OfficerJul 13, 2012 Option Exercise$60.0418,2001,092,72826,013Jul 17, 2012, 03:02 PM
Fonseca LidiaChief Information OfficerJul 13, 2012 Sale$95.0018,2001,729,0007,813Jul 17, 2012, 03:02 PM
KING DAVID PPresident & CEOJul 09, 2012 Option Exercise$59.4384,8005,039,942195,032Jul 11, 2012, 02:54 PM
KING DAVID PPresident & CEOJul 09, 2012 Sale$92.1184,8007,810,928110,232Jul 11, 2012, 02:54 PM
Fonseca LidiaChief Information OfficerJun 27, 2012 Sale$90.001,687151,8307,813Jun 29, 2012, 03:36 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryJun 04, 2012 Sale$83.832,678224,50419,119Jun 06, 2012, 05:08 PM
BELINGARD JEAN-LUCDirectorMay 11, 2012 Option Exercise$86.72242,08124,985May 15, 2012, 01:41 PM
BELINGARD JEAN-LUCDirectorMay 14, 2012 Option Exercise$85.33302,56024,955May 15, 2012, 01:41 PM
LANE WENDY EDirectorMay 09, 2012 Option Exercise$48.0267732,51014,480May 11, 2012, 02:36 PM
LANE WENDY EDirectorMay 09, 2012 Sale$85.9851043,85114,470May 11, 2012, 02:36 PM
LANE WENDY EDirectorMay 08, 2012 Option Exercise$64.4261739,74714,587May 10, 2012, 09:37 AM
LANE WENDY EDirectorMay 08, 2012 Sale$86.4680069,17014,070May 10, 2012, 09:37 AM
BELINGARD JEAN-LUCDirectorMay 07, 2012 Option Exercise$87.04373,22025,009May 09, 2012, 10:46 AM
BELINGARD JEAN-LUCDirectorMay 01, 2012 Option Exercise$48.021,35364,97126,399May 03, 2012, 03:39 PM
BELINGARD JEAN-LUCDirectorMay 01, 2012 Sale$88.111,353119,21826,151May 03, 2012, 03:39 PM
Walton Andrew ScottEVPApr 09, 2012 Sale$91.824,000367,28024,298Apr 11, 2012, 02:57 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 26, 2012 Option Exercise$91.908,315764,14937,320Mar 28, 2012, 04:35 PM
KING DAVID PPresident & CEOMar 26, 2012 Option Exercise$91.9027,6902,544,711153,784Mar 28, 2012, 04:31 PM
Hayes William BChief Financial Officer, EVPMar 26, 2012 Option Exercise$91.9010,137931,59037,819Mar 28, 2012, 04:23 PM
Hayes William BChief Financial Officer, EVPMar 26, 2012 Option Exercise$70.152,750192,91326,828Mar 28, 2012, 04:23 PM
Hayes William BChief Financial Officer, EVPMar 26, 2012 Sale$90.002,750247,50024,078Mar 28, 2012, 04:23 PM
Hayes William BChief Financial Officer, EVPMar 27, 2012 Sale$91.6713,7411,259,58724,078Mar 28, 2012, 04:23 PM
Walton Andrew ScottEVPMar 26, 2012 Option Exercise$91.904,999459,40826,298Mar 28, 2012, 04:22 PM
Brecher Mark EChief Medical OfficerMar 26, 2012 Option Exercise$91.901,607147,6839,286Mar 28, 2012, 04:17 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 26, 2012 Option Exercise$91.901,559143,27221,497Mar 28, 2012, 04:16 PM
Fonseca LidiaChief Information OfficerMar 26, 2012 Option Exercise$91.901,559143,2729,500Mar 28, 2012, 04:15 PM
Hayes William BChief Financial Officer, EVPMar 23, 2012 Option Exercise$65.8972,0834,749,612100,648Mar 27, 2012, 03:58 PM
Hayes William BChief Financial Officer, EVPMar 23, 2012 Sale$89.6876,5706,866,83183,941Mar 27, 2012, 03:58 PM
MAC MAHON THOMAS PDirectorFeb 29, 2012 Sale$89.9860,0005,398,81265,497Mar 02, 2012, 03:26 PM
Walton Andrew ScottEVPFeb 10, 2012 Option Exercise$90.0346641,95417,221Feb 13, 2012, 03:38 PM
Walton Andrew ScottEVPFeb 09, 2012 Option Exercise$92.1172666,87218,001Feb 13, 2012, 03:38 PM
Hayes William BChief Financial Officer, EVPFeb 09, 2012 Option Exercise$92.111,292119,00623,027Feb 13, 2012, 03:37 PM
Hayes William BChief Financial Officer, EVPFeb 10, 2012 Option Exercise$90.0388879,94721,565Feb 13, 2012, 03:37 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 10, 2012 Option Exercise$90.0346641,95415,888Feb 13, 2012, 03:36 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 09, 2012 Option Exercise$92.111,268116,79516,939Feb 13, 2012, 03:36 PM
KING DAVID PPresident & CEOFeb 10, 2012 Option Exercise$90.033,170285,39594,146Feb 13, 2012, 03:36 PM
KING DAVID PPresident & CEOFeb 09, 2012 Option Exercise$92.114,721434,85199,679Feb 13, 2012, 03:36 PM
Fonseca LidiaChief Information OfficerFeb 10, 2012 Option Exercise$90.0317415,6654,855Feb 13, 2012, 03:34 PM
Fonseca LidiaChief Information OfficerFeb 09, 2012 Option Exercise$92.1129627,2655,153Feb 13, 2012, 03:34 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 10, 2012 Option Exercise$90.0317415,66517,072Feb 13, 2012, 03:34 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 09, 2012 Option Exercise$92.1129627,26517,370Feb 13, 2012, 03:34 PM
Brecher Mark EChief Medical OfficerFeb 10, 2012 Option Exercise$90.0318416,5664,543Feb 13, 2012, 03:33 PM
Brecher Mark EChief Medical OfficerFeb 09, 2012 Option Exercise$92.1175169,1755,294Feb 13, 2012, 03:33 PM
KING DAVID PPresident & CEOJan 25, 2012 Option Exercise$58.5720,0001,171,400122,037Jan 27, 2012, 04:09 PM
KING DAVID PPresident & CEOJan 25, 2012 Sale$92.0020,0001,840,000102,037Jan 27, 2012, 04:09 PM
KING DAVID PPresident & CEODec 02, 2011 Option Exercise$47.8920,000957,800121,957Dec 06, 2011, 02:57 PM
KING DAVID PPresident & CEODec 02, 2011 Sale$88.0020,0001,760,000101,957Dec 06, 2011, 02:57 PM
MITTELSTAEDT ROBERT E JRDirectorAug 18, 2011 Option Exercise$48.021,35364,97112,925Aug 22, 2011, 01:51 PM
MITTELSTAEDT ROBERT E JRDirectorAug 18, 2011 Sale$79.9681765,32912,108Aug 22, 2011, 01:51 PM
Williams R SandersDirectorMay 19, 2011 Option Exercise$75.946,292477,7989,812May 23, 2011, 01:01 PM
Williams R SandersDirectorMay 19, 2011 Sale$100.736,292633,7698,912May 23, 2011, 01:01 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMay 13, 2011 Option Exercise$78.7515,2001,196,97632,742May 17, 2011, 03:10 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMay 13, 2011 Sale$99.0415,2001,505,47917,542May 17, 2011, 03:10 PM
BELINGARD JEAN-LUCDirectorMay 12, 2011 Option Exercise$100.00303,00025,046May 13, 2011, 05:23 PM
BELINGARD JEAN-LUCDirectorMay 11, 2011 Option Exercise$34.251,89664,93826,272May 13, 2011, 05:23 PM
BELINGARD JEAN-LUCDirectorMay 11, 2011 Sale$98.791,896187,29825,172May 13, 2011, 05:23 PM
BELINGARD JEAN-LUCDirectorMay 09, 2011 Option Exercise$98.48302,95424,376May 10, 2011, 03:35 PM
BELINGARD JEAN-LUCDirectorMay 06, 2011 Option Exercise$97.59373,61124,406May 10, 2011, 03:35 PM
LANE WENDY EDirectorApr 25, 2011 Option Exercise$96.1033932,57913,453Apr 27, 2011, 04:04 PM
LANE WENDY EDirectorApr 25, 2011 Option Exercise$34.2594832,46913,792Apr 27, 2011, 04:04 PM
KING DAVID PPresident & CEOApr 25, 2011 Sale$95.867,254695,368101,765Apr 27, 2011, 04:03 PM
Brecher Mark EChief Medical OfficerApr 21, 2011 Sale$98.001,271124,5585,828Apr 22, 2011, 11:23 AM
MAC MAHON THOMAS PDirectorApr 14, 2011 Option Exercise$58.5771,1334,166,260175,930Apr 18, 2011, 03:10 PM
MAC MAHON THOMAS PDirectorApr 15, 2011 Option Exercise$58.57103,8676,083,490208,664Apr 18, 2011, 03:10 PM
MAC MAHON THOMAS PDirectorApr 15, 2011 Sale$95.9783,8678,048,482130,797Apr 18, 2011, 03:10 PM
MAC MAHON THOMAS PDirectorApr 14, 2011 Sale$95.0071,1336,757,855104,797Apr 18, 2011, 03:10 PM
Walton Andrew ScottEVPApr 14, 2011 Sale$95.001,535145,82518,413Apr 18, 2011, 03:08 PM
Walton Andrew ScottEVPApr 11, 2011 Sale$92.691,536142,37219,948Apr 13, 2011, 02:50 PM
Walton Andrew ScottEVPMar 30, 2011 Option Exercise$91.571,780162,99521,484Apr 01, 2011, 05:14 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 30, 2011 Option Exercise$91.5778071,42517,622Apr 01, 2011, 05:13 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 30, 2011 Option Exercise$91.5759754,66717,542Apr 01, 2011, 05:12 PM
Fonseca LidiaChief Information OfficerMar 30, 2011 Option Exercise$91.5759754,6675,325Apr 01, 2011, 05:11 PM
KING DAVID PPresident & CEOMar 30, 2011 Option Exercise$91.5710,702979,982109,019Apr 01, 2011, 05:09 PM
Hayes William BChief Financial Officer, EVPMar 30, 2011 Option Exercise$91.573,963362,89229,116Apr 01, 2011, 05:08 PM
Hayes William BChief Financial Officer, EVPMar 31, 2011 Sale$91.215,371489,86623,745Apr 01, 2011, 05:08 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 14, 2011 Option Exercise$87.7314112,37016,302Feb 16, 2011, 03:33 PM
Hayes William BChief Financial Officer, EVPFeb 14, 2011 Option Exercise$87.7389278,25524,953Feb 16, 2011, 03:30 PM
Hayes William BChief Financial Officer, EVPFeb 15, 2011 Sale$87.451,208105,64023,745Feb 16, 2011, 03:30 PM
Walton Andrew ScottEVPFeb 14, 2011 Option Exercise$87.7335731,32018,413Feb 16, 2011, 03:27 PM
KING DAVID PPresident & CEOFeb 14, 2011 Option Exercise$87.732,435213,62394,511Feb 16, 2011, 03:23 PM
Fonseca LidiaChief Information OfficerFeb 14, 2011 Option Exercise$87.7314112,3704,085Feb 16, 2011, 03:19 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 14, 2011 Option Exercise$87.7314112,37016,565Feb 16, 2011, 03:18 PM
Hayes William BChief Financial Officer, EVPFeb 11, 2011 Sale$87.181,846160,93425,845Feb 15, 2011, 12:08 PM
Hayes William BChief Financial Officer, EVPFeb 09, 2011 Option Exercise$90.7471865,15124,726Feb 11, 2011, 05:46 PM
Hayes William BChief Financial Officer, EVPFeb 10, 2011 Option Exercise$87.7388777,81758,058Feb 11, 2011, 05:46 PM
Hayes William BChief Financial Officer, EVPFeb 10, 2011 Option Exercise$60.0430,3671,823,23558,945Feb 11, 2011, 05:46 PM
Hayes William BChief Financial Officer, EVPFeb 10, 2011 Sale$88.1831,8152,805,42530,591Feb 11, 2011, 05:46 PM
KING DAVID PPresident & CEOFeb 09, 2011 Option Exercise$90.742,077188,46782,938Feb 11, 2011, 05:16 PM
KING DAVID PPresident & CEOFeb 10, 2011 Option Exercise$87.732,692236,16996,946Feb 11, 2011, 05:16 PM
Conrad Andrew JEVP, Chief Scientific OfficerFeb 10, 2011 Option Exercise$87.7351445,09326,541Feb 11, 2011, 05:13 PM
Conrad Andrew JEVP, Chief Scientific OfficerFeb 09, 2011 Option Exercise$90.7449645,00727,055Feb 11, 2011, 05:13 PM
Brecher Mark EChief Medical OfficerFeb 10, 2011 Option Exercise$87.7318416,1426,749Feb 11, 2011, 04:40 PM
Brecher Mark EChief Medical OfficerFeb 09, 2011 Option Exercise$90.741,07597,5452,624Feb 11, 2011, 04:40 PM
Walton Andrew ScottEVPFeb 10, 2011 Option Exercise$87.7346640,88218,770Feb 11, 2011, 04:40 PM
Walton Andrew ScottEVPFeb 09, 2011 Option Exercise$90.7441237,38516,336Feb 11, 2011, 04:40 PM
Fonseca LidiaChief Information OfficerFeb 10, 2011 Option Exercise$87.7317815,6164,226Feb 11, 2011, 04:36 PM
Fonseca LidiaChief Information OfficerFeb 09, 2011 Option Exercise$90.7417115,5173,304Feb 11, 2011, 04:36 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 10, 2011 Option Exercise$87.7346640,88216,706Feb 11, 2011, 04:30 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 09, 2011 Option Exercise$90.7468562,15711,772Feb 11, 2011, 04:30 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 10, 2011 Option Exercise$87.7317815,61616,443Feb 11, 2011, 04:28 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 09, 2011 Option Exercise$90.7417115,51715,521Feb 11, 2011, 04:28 PM
Hayes William BChief Financial Officer, EVPDec 27, 2010 Option Exercise$60.0430,3661,823,17555,810Dec 28, 2010, 02:04 PM
Hayes William BChief Financial Officer, EVPDec 27, 2010 Sale$87.9530,3662,670,70225,444Dec 28, 2010, 02:04 PM
MAC MAHON THOMAS PDirectorDec 01, 2010 Option Exercise$47.89175,0008,380,750259,797Dec 03, 2010, 09:21 AM
MAC MAHON THOMAS PDirectorDec 01, 2010 Sale$85.00155,00013,175,000104,797Dec 03, 2010, 09:21 AM
Walton Andrew ScottEVPOct 29, 2010 Sale$81.0088171,36116,748Nov 02, 2010, 05:16 PM
Walton Andrew ScottEVPOct 29, 2010 Sale$81.0088171,36116,748Nov 02, 2010, 05:16 PM
Walton Andrew ScottEVPOct 29, 2010 Sale$81.0088171,36116,748Nov 02, 2010, 08:27 AM
Walton Andrew ScottEVPOct 29, 2010 Sale$81.0088171,36116,748Nov 02, 2010, 08:27 AM
Hayes William BChief Financial Officer, EVPOct 13, 2010 Option Exercise$58.5730,0001,757,10055,444Oct 15, 2010, 02:45 PM
Hayes William BChief Financial Officer, EVPOct 13, 2010 Sale$80.0030,0002,400,00025,444Oct 15, 2010, 02:45 PM
Walton Andrew ScottEVPOct 06, 2010 Option Exercise$58.575,000292,85022,629Oct 08, 2010, 04:15 PM
Walton Andrew ScottEVPOct 06, 2010 Sale$79.505,000397,50017,629Oct 08, 2010, 04:15 PM
Walton Andrew ScottEVPOct 01, 2010 Sale$79.0088169,59917,629Oct 05, 2010, 04:54 PM
Walton Andrew ScottEVPOct 01, 2010 Sale$79.0088169,59917,629Oct 05, 2010, 04:54 PM
MITTELSTAEDT ROBERT E JRDirectorSep 08, 2010 Option Exercise$34.251,89664,93813,304Sep 10, 2010, 10:31 AM
MITTELSTAEDT ROBERT E JRDirectorSep 08, 2010 Sale$74.321,896140,90613,204Sep 10, 2010, 10:31 AM
Conrad Andrew JEVP, Chief Scientific OfficerJul 26, 2010 Buy$74.326,100453,3476,100Jul 30, 2010, 11:07 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Seltz Judith CEVP, CHRO02/02/202319,634
van der Vaart Sandra DEVP, Chief Legal Officer02/02/202316,319
van der Vaart Sandra DEVP, Chief Legal Officer02/03/202343,925
Wilkinson Peter JSVP, Chief Accounting Officer02/02/202310,455
Summy Amy B.EVP, Chief Marketing Officer02/02/202319,634
Schroeder Mark SEVP, President-Diagnostics Lab02/02/202330,344
Schroeder Mark SEVP, President-Diagnostics Lab02/03/202382,264
Schechter Adam HPresident & CEO02/02/2023205,267
Kirchgraber Paul RCEO, Covance Drug Development02/02/202335,954
EISENBERG GLENN AChief Financial Officer, EVP02/02/202352,528
Caveney Brian JEVP, President of Diagnostics02/02/202336,719
BERBERIAN LANCEEVP, CIO & CTO02/02/202326,009
Schroeder Mark SEVP, President-Diagnostics Lab11/08/2022259,660
Schroeder Mark SEVP, President-Diagnostics Lab11/07/2022208,990
Caveney Brian JEVP, President of Diagnostics11/07/2022208,990
EISENBERG GLENN AChief Financial Officer, EVP11/01/20221,190,251
Schechter Adam HPresident & CEO11/01/2022198,746
Kirchgraber Paul RCEO, Covance Drug Development11/01/2022198,524
EISENBERG GLENN AChief Financial Officer, EVP09/26/20225,265,581
Caveney Brian JEVP, President of Diagnostics09/07/202210,173
EISENBERG GLENN AChief Financial Officer, EVP08/03/20224,722,543
EISENBERG GLENN AChief Financial Officer, EVP08/03/20228,151,450
Wilkinson Peter JSVP, Chief Accounting Officer08/01/20225,933
Wilkinson Peter JSVP, Chief Accounting Officer08/01/2022112,435
Wilkinson Peter JSVP, Chief Accounting Officer08/01/2022665,634
Caveney Brian JEVP, President of Diagnostics06/07/202210,172
Schroeder Mark SEVP, President-Diagnostics Lab03/29/2022652,871
van der Vaart Sandra DEVP, Chief Legal Officer03/29/2022678,642
BERBERIAN LANCEEVP, CIO & CTO03/28/2022652,351
Caveney Brian JEVP, President of Diagnostics03/28/2022520,499
EISENBERG GLENN AChief Financial Officer, EVP03/28/20221,737,576
Kirchgraber Paul RCEO, Covance Drug Development03/28/2022455,540
Schroeder Mark SEVP, President-Diagnostics Lab03/28/2022521,052
van der Vaart Sandra DEVP, Chief Legal Officer03/28/2022495,345
Wilkinson Peter JSVP, Chief Accounting Officer03/28/2022252,924
Williams R SandersDirector03/25/2022156,145
Summy Amy B.EVP, Chief Marketing Officer03/10/202265,290
NEUPERT PETER MDirector02/16/2022922,815
Schroeder Mark SEVP, President-Diagnostics Lab02/15/202256,714
van der Vaart Sandra DEVP, Chief Legal Officer02/15/202256,714
Wilkinson Peter JSVP, Chief Accounting Officer02/14/202271,169
Caveney Brian JEVP, President of Diagnostics02/14/2022212,145
EISENBERG GLENN AChief Financial Officer, EVP02/14/202275,532
Kirchgraber Paul RCEO, Covance Drug Development02/14/202229,449
BERBERIAN LANCEEVP, CIO & CTO02/14/2022217,871
Schroeder Mark SEVP, President-Diagnostics Lab02/14/202220,996
van der Vaart Sandra DEVP, Chief Legal Officer02/14/202220,996
BERBERIAN LANCEEVP, CIO & CTO02/04/202230,245
Caveney Brian JEVP, President of Diagnostics02/04/202245,784
EISENBERG GLENN AChief Financial Officer, EVP02/04/202279,359
Kirchgraber Paul RCEO, Covance Drug Development02/04/202245,784
Schechter Adam HPresident & CEO02/04/2022391,802
Schroeder Mark SEVP, President-Diagnostics Lab02/04/202242,177
Schroeder Mark SEVP, President-Diagnostics Lab02/07/202256,586
Seltz Judith CEVP, CHRO02/04/202223,586
Summy Amy B.EVP, Chief Marketing Officer02/04/202223,031
van der Vaart Sandra DEVP, Chief Legal Officer02/04/202222,753
van der Vaart Sandra DEVP, Chief Legal Officer02/07/202260,469
Wilkinson Peter JSVP, Chief Accounting Officer02/04/202214,706
Schroeder Mark SEVP, President-Diagnostics Lab02/02/202233,055
Schroeder Mark SEVP, President-Diagnostics Lab02/03/202243,761
van der Vaart Sandra DEVP, Chief Legal Officer02/02/202217,484
van der Vaart Sandra DEVP, Chief Legal Officer02/03/202246,751
Summy Amy B.EVP, Chief Marketing Officer02/02/202221,035
Kirchgraber Paul RCEO, Covance Drug Development02/02/202239,338
Seltz Judith CEVP, CHRO02/02/202220,762
Wilkinson Peter JSVP, Chief Accounting Officer02/02/202211,200
Caveney Brian JEVP, President of Diagnostics02/02/202240,157
Schechter Adam HPresident & CEO02/02/2022219,364
EISENBERG GLENN AChief Financial Officer, EVP02/02/202264,470
BERBERIAN LANCEEVP, CIO & CTO02/02/202228,138
BELINGARD JEAN-LUCDirector02/02/202221,308
Gilliland Dwight GaryDirector12/15/2021151,128
Caveney Brian JEVP, President of Diagnostics11/05/2021247,081
Schroeder Mark SEVP, President-Diagnostics Lab11/05/2021247,081
Schechter Adam HPresident & CEO11/01/2021255,859
EISENBERG GLENN AChief Financial Officer, EVP11/01/20211,164,939
Kirchgraber Paul RCEO, Covance Drug Development11/01/2021259,324
van der Vaart Sandra DEVP, Chief Legal Officer09/15/2021381,870
van der Vaart Sandra DEVP, Chief Legal Officer09/15/20211,335,510
Wilkinson Peter JSVP, Chief Accounting Officer08/02/20214,464
van der Vaart Sandra DEVP, Chief Legal Officer06/07/2021381,870
van der Vaart Sandra DEVP, Chief Legal Officer06/07/20211,199,520
BELINGARD JEAN-LUCDirector05/03/2021256,074
BELINGARD JEAN-LUCDirector05/03/2021699,803
Kirchgraber Paul RCEO, Covance Drug Development04/03/2021114,207
Schroeder Mark SEVP, President-Diagnostics Lab03/30/2021168,004
van der Vaart Sandra DEVP, Chief Legal Officer03/30/2021204,527
EISENBERG GLENN AChief Financial Officer, EVP03/27/2021904,430
BERBERIAN LANCEEVP, CIO & CTO03/27/2021271,455
Caveney Brian JEVP, President of Diagnostics03/27/2021271,455
Kirchgraber Paul RCEO, Covance Drug Development03/27/2021198,748
Schroeder Mark SEVP, President-Diagnostics Lab03/27/2021271,455
van der Vaart Sandra DEVP, Chief Legal Officer03/27/2021172,835
Wilkinson Peter JSVP, Chief Accounting Officer02/12/202162,662
Wilkinson Peter JSVP, Chief Accounting Officer02/18/2021340,251
Wilkinson Peter JSVP, Chief Accounting Officer02/18/2021559,590
van der Vaart Sandra DEVP, Chief Legal Officer02/12/202137,645
van der Vaart Sandra DEVP, Chief Legal Officer02/16/202149,202
Schroeder Mark SEVP, President-Diagnostics Lab02/12/202133,833
Schroeder Mark SEVP, President-Diagnostics Lab02/16/202144,567
Kirchgraber Paul RCEO, Covance Drug Development02/12/202142,887
EISENBERG GLENN AChief Financial Officer, EVP02/12/2021121,989
Caveney Brian JEVP, President of Diagnostics02/12/2021203,474
BERBERIAN LANCEEVP, CIO & CTO02/12/2021208,001
Schechter Adam HPresident & CEO02/04/2021230,046
Wilkinson Peter JSVP, Chief Accounting Officer02/04/202111,860
van der Vaart Sandra DEVP, Chief Legal Officer02/04/202118,574
van der Vaart Sandra DEVP, Chief Legal Officer02/05/202124,618
Summy Amy B.EVP, Chief Marketing Officer02/04/202121,035
Schroeder Mark SEVP, President-Diagnostics Lab02/04/202134,462
Schroeder Mark SEVP, President-Diagnostics Lab02/05/202145,848
Kirchgraber Paul RCEO, Covance Drug Development02/04/202141,847
EISENBERG GLENN AChief Financial Officer, EVP02/04/202168,477
Caveney Brian JEVP, President of Diagnostics02/04/202142,518
BERBERIAN LANCEEVP, CIO & CTO02/04/202129,315
Seltz Judith CEVP, CHRO02/04/202121,483
BELINGARD JEAN-LUCDirector02/04/202122,154
Williams R SandersDirector01/26/2021128,037
Schroeder Mark SEVP, President-Diagnostics Lab11/06/2020126,179
Caveney Brian JEVP, President of Diagnostics11/05/2020189,976
Schroeder Mark SEVP, President-Diagnostics Lab11/05/2020179,041
Kirchgraber Paul RCEO, Covance Drug Development11/04/2020321,204
EISENBERG GLENN AChief Financial Officer, EVP11/02/2020835,966
Schechter Adam HPresident & CEO11/02/2020183,399
Kirchgraber Paul RCEO, Covance Drug Development11/02/2020185,471
Caveney Brian JEVP, President of Diagnostics09/25/202052,306
Williams R SandersDirector07/08/2020128,037
Williams R SandersDirector07/08/2020225,056
van der Vaart Sandra DEVP, Chief Legal Officer07/02/202073,950
van der Vaart Sandra DEVP, Chief Legal Officer06/24/2020139,808
KING DAVID PDirector05/05/20205,000,000
Seltz Judith CEVP, CHRO03/10/202055,625
Seltz Judith CEVP, CHRO02/28/202043,735
Kirchgraber Paul RCEO, Covance Drug Development04/03/202042,151
KING DAVID PDirector03/30/20203,243,727
van der Vaart Sandra DEVP, Chief Legal Officer03/30/2020145,937
EISENBERG GLENN AChief Financial Officer, EVP03/30/2020763,595
Kirchgraber Paul RCEO, Covance Drug Development03/30/2020133,797
Schroeder Mark SEVP, President-Diagnostics Lab03/30/2020152,138
BERBERIAN LANCEEVP, CIO & CTO03/30/2020223,655
Wilkinson Peter JSVP, Chief Accounting Officer02/21/202056,326
BELINGARD JEAN-LUCDirector02/19/2020239,289
BELINGARD JEAN-LUCDirector02/19/20205,024,761
EISENBERG GLENN AChief Financial Officer, EVP02/12/202096,005
van der Vaart Sandra DSVP, Global General Counsel02/12/202029,627
van der Vaart Sandra DSVP, Global General Counsel02/13/202039,206
Schroeder Mark SEVP, President-Diagnostics Lab02/12/202026,626
Schroeder Mark SEVP, President-Diagnostics Lab02/13/202035,436
BERBERIAN LANCESVP, Chief Information Officer02/12/2020163,509
Caveney Brian JEVP, President of Diagnostics02/12/2020162,384
Wilkinson Peter JSVP, Chief Accounting Officer02/12/202051,003
Kirchgraber Paul RCEO, Covance Drug Development02/12/202029,814
KING DAVID PDirector02/12/2020615,033
BELINGARD JEAN-LUCDirector02/12/202023,064
Williams R SandersDirector02/13/2020231,277
Schroeder Mark SEVP, President-Diagnostics Lab02/07/202014,951
Schroeder Mark SEVP, President-Diagnostics Lab02/10/202019,655
van der Vaart Sandra DSVP, Global General Counsel02/07/202018,415
van der Vaart Sandra DSVP, Global General Counsel02/10/202024,205
Kirchgraber Paul RCEO, Covance Drug Development02/07/202018,780
KING DAVID PDirector02/07/2020228,277
EISENBERG GLENN AChief Financial Officer, EVP02/07/202053,787
BERBERIAN LANCESVP, Chief Information Officer02/07/202018,780
BELINGARD JEAN-LUCDirector12/04/201956,185
KING DAVID PPresident & CEO10/28/20194,991,216
ANDERSON KERRII BDirector09/23/2019256,074
ANDERSON KERRII BDirector09/23/2019446,810
Uthgenannt Lisa JChief Human Resources Officer09/04/2019322,060
Uthgenannt Lisa JChief Human Resources Officer09/04/2019415,743
BERBERIAN LANCESVP, Chief Information Officer08/30/20191,002,171
Williams R SandersDirector08/05/201981,455
EISENBERG GLENN AChief Financial Officer, EVP07/08/2019983,260
van der Vaart Sandra DSVP, Global General Counsel07/08/2019411,474
ANDERSON KERRII BDirector06/20/2019239,289
ANDERSON KERRII BDirector06/20/2019527,000
EISENBERG GLENN AChief Financial Officer, EVP06/07/20191,673,971
Williams R SandersDirector05/06/201981,100
MITTELSTAEDT ROBERT E JRDirector05/03/2019238,354
MITTELSTAEDT ROBERT E JRDirector05/03/2019615,310
Uthgenannt Lisa JChief Human Resources Officer05/02/2019656,000
Ratliff John DCEO, Covance Drug Development04/03/2019169,841
KING DAVID PPresident & CEO04/01/20196,394,529
EISENBERG GLENN AChief Financial Officer, EVP04/01/20191,549,912
van der Vaart Sandra DSVP, Global General Counsel04/01/2019275,836
Dodson Edward TPrincipal Accounting Officer04/01/2019275,371
Uthgenannt Lisa JChief Human Resources Officer04/01/2019500,900
BERBERIAN LANCESVP, Chief Information Officer04/01/2019354,005
BELINGARD JEAN-LUCDirector02/12/201915,245
BELINGARD JEAN-LUCDirector02/12/2019238,354
BELINGARD JEAN-LUCDirector02/12/2019540,407
KING DAVID PPresident & CEO02/12/2019230,293
Williams R SandersDirector02/13/2019152,586
Dodson Edward TPrincipal Accounting Officer02/12/20197,916
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/12/20199,382
Ratliff John DCEO, Covance Drug Development02/12/201995,870
EISENBERG GLENN AChief Financial Officer, EVP02/12/201934,009
BERBERIAN LANCESVP, Chief Information Officer02/12/201910,261
Caveney Brian JSVP, Chief Medical Officer02/12/201912,020
Uthgenannt Lisa JChief Human Resources Officer02/12/201915,099
Uthgenannt Lisa JChief Human Resources Officer02/11/201934,630
Dodson Edward TPrincipal Accounting Officer02/11/201917,892
KING DAVID PPresident & CEO02/11/2019429,984
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/11/201920,633
EISENBERG GLENN AChief Financial Officer, EVP02/11/2019209,076
BERBERIAN LANCESVP, Chief Information Officer02/11/2019149,629
Ratliff John DCEO, Covance Drug Development02/11/2019284,684
Ratliff John DCEO, Covance Drug Development02/07/201981,988
KING DAVID PPresident & CEO02/07/2019184,915
EISENBERG GLENN AChief Financial Officer, EVP02/07/201943,796
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/07/201912,092
Dodson Edward TPrincipal Accounting Officer02/07/201910,027
Uthgenannt Lisa JChief Human Resources Officer02/07/201921,824
BERBERIAN LANCESVP, Chief Information Officer02/07/201915,336
Williams R SandersDirector11/27/201856,749
ANDERSON KERRII BDirector11/05/2018238,354
ANDERSON KERRII BDirector11/05/2018604,162
Gary M. HuffCEO, LabCorp Diagnostics09/04/201811,671
Dodson Edward TPrincipal Accounting Officer06/06/20181,103,180
Dodson Edward TPrincipal Accounting Officer06/06/20182,383,563
Uthgenannt Lisa JChief Human Resources Officer06/04/2018819,450
Gilliland Dwight GaryDirector05/31/2018228,967
BERBERIAN LANCESVP, Chief Information Officer05/31/20181,002,672
Gary M. HuffCEO, LabCorp Diagnostics05/30/2018293,823
EISENBERG GLENN AChief Financial Officer, EVP05/30/20181,812,067
KING DAVID PPresident & CEO05/23/20184,240,115
KING DAVID PPresident & CEO05/23/20188,762,352
KING DAVID PPresident & CEO04/23/20184,240,200
KING DAVID PPresident & CEO04/23/20188,300,692
Gary M. HuffCEO, LabCorp Diagnostics04/04/2018225,444
BERBERIAN LANCESVP, Chief Information Officer03/29/2018343,072
Dodson Edward TPrincipal Accounting Officer03/29/2018258,800
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/29/2018348,086
EISENBERG GLENN AChief Financial Officer, EVP03/29/20181,431,488
KING DAVID PPresident & CEO03/29/20185,340,176
Uthgenannt Lisa JChief Human Resources Officer03/29/2018457,429
KING DAVID PPresident & CEO03/23/20184,240,200
KING DAVID PPresident & CEO03/23/20188,232,224
Dodson Edward TPrincipal Accounting Officer03/12/201819,493
KING DAVID PPresident & CEO03/12/2018479,767
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/12/201822,654
EISENBERG GLENN AChief Financial Officer, EVP03/12/2018128,547
BERBERIAN LANCESVP, Chief Information Officer03/12/201821,073
Uthgenannt Lisa JChief Human Resources Officer03/12/201832,312
EISENBERG GLENN AChief Financial Officer, EVP02/12/20181,405,839
Ratliff John DCEO, Covance Drug Development02/09/2018358,347
ANDERSON KERRII BDirector02/09/2018249,579
ANDERSON KERRII BDirector02/09/2018548,123
EISENBERG GLENN AChief Financial Officer, EVP02/09/2018245,733
BERBERIAN LANCESVP, Chief Information Officer02/09/2018176,148
Dodson Edward TPrincipal Accounting Officer02/09/201828,069
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/09/201824,204
Uthgenannt Lisa JChief Human Resources Officer02/09/201834,120
KING DAVID PPresident & CEO02/09/2018527,435
Uthgenannt Lisa JChief Human Resources Officer02/07/201821,886
KING DAVID PPresident & CEO02/07/2018214,450
Ratliff John DCEO, Covance Drug Development02/07/201895,010
Gary M. HuffCEO, LabCorp Diagnostics02/07/201855,818
EISENBERG GLENN AChief Financial Officer, EVP02/07/201850,728
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/07/201813,912
Dodson Edward TPrincipal Accounting Officer02/07/201815,609
BERBERIAN LANCESVP, Chief Information Officer02/07/201817,814
Schechter Adam HDirector02/08/2018213,813
BELINGARD JEAN-LUCDirector02/07/201821,547
Gilliland Dwight GaryDirector10/30/2017149,068
Gary M. HuffCEO, LabCorp Diagnostics09/01/20178,038
KING DAVID PPresident & CEO09/06/20174,054,898
KING DAVID PPresident & CEO09/06/20177,009,789
KING DAVID PPresident & CEO09/05/201712,042,377
KING DAVID PPresident & CEO09/05/201720,843,373
EBERTS F SAMUEL IIIChief Legal Officer, Secretary08/25/20172,177,239
EBERTS F SAMUEL IIIChief Legal Officer, Secretary08/25/20174,889,461
Williams R SandersDirector08/11/2017239,289
Williams R SandersDirector08/11/2017486,338
Dodson Edward TPrincipal Accounting Officer08/01/2017459,740
Uthgenannt Lisa JChief Human Resources Officer08/01/2017800,000
EISENBERG GLENN AChief Financial Officer, EVP08/01/2017951,669
EISENBERG GLENN AChief Financial Officer, EVP06/16/2017271,123
BERBERIAN LANCESVP, Chief Information Officer05/22/2017505,260
BELINGARD JEAN-LUCDirector05/09/201776,959
BELINGARD JEAN-LUCDirector05/09/2017141,052
BERBERIAN LANCESVP, Chief Information Officer03/29/2017449,903
Dodson Edward TPrincipal Accounting Officer03/29/2017408,092
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/29/2017459,926
EISENBERG GLENN AChief Financial Officer, EVP03/29/20171,396,532
KING DAVID PPresident & CEO03/29/20176,958,461
Uthgenannt Lisa JChief Human Resources Officer03/13/2017527,053
BERBERIAN LANCESVP, Chief Information Officer03/13/201719,040
Dodson Edward TPrincipal Accounting Officer03/13/201721,492
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/13/201722,069
EISENBERG GLENN AChief Financial Officer, EVP03/13/2017111,642
KING DAVID PPresident & CEO03/13/2017416,854
EISENBERG GLENN AChief Financial Officer, EVP03/09/2017327,691
MITTELSTAEDT ROBERT E JRDirector02/24/2017400,839
MITTELSTAEDT ROBERT E JRDirector02/24/2017756,256
ANDERSON KERRII BDirector02/24/201775,630
ANDERSON KERRII BDirector02/23/2017152,589
ANDERSON KERRII BDirector02/23/2017278,880
Dodson Edward TPrincipal Accounting Officer02/13/201724,557
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/13/201727,796
EISENBERG GLENN AChief Financial Officer, EVP02/13/201774,481
BERBERIAN LANCESVP, Chief Information Officer02/13/201765,981
KING DAVID PPresident & CEO02/13/2017535,402
BERBERIAN LANCESVP, Chief Information Officer02/13/201765,981
Uthgenannt Lisa JChief Human Resources Officer02/09/201732,655
Dodson Edward TPrincipal Accounting Officer02/09/201718,469
Ratliff John DCEO, Covance Drug Development02/09/2017269,400
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/09/201725,160
EISENBERG GLENN AChief Financial Officer, EVP02/09/2017215,466
BERBERIAN LANCESVP, Chief Information Officer02/09/2017156,715
KING DAVID PPresident & CEO02/09/2017334,040
BELINGARD JEAN-LUCDirector02/09/201720,877
Uthgenannt Lisa JChief Human Resources Officer08/09/2016164,780
EISENBERG GLENN AChief Financial Officer, EVP08/04/20161,120,804
MITTELSTAEDT ROBERT E JRDirector08/04/201676,959
MITTELSTAEDT ROBERT E JRDirector08/04/2016139,027
EISENBERG GLENN AChief Financial Officer, EVP06/16/2016246,550
KING DAVID PPresident & CEO06/13/201613,777,460
KING DAVID PPresident & CEO06/13/201625,139,088
Uthgenannt Lisa JChief Human Resources Officer04/29/2016468,136
Dodson Edward TPrincipal Accounting Officer04/27/20161,187,337
KING DAVID PPresident & CEO03/30/20165,706,886
EISENBERG GLENN AChief Financial Officer, EVP03/30/2016707,925
Dodson Edward TPrincipal Accounting Officer03/30/2016276,830
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/30/2016290,618
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/31/2016492,990
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics03/30/20161,956,899
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics03/31/20162,118,030
BELINGARD JEAN-LUCDirector03/11/201614,321
BERBERIAN LANCESVP, Chief Information Officer03/11/201615,360
Dodson Edward TPrincipal Accounting Officer03/11/201614,321
EISENBERG GLENN AChief Financial Officer, EVP03/11/201689,851
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/11/201617,785
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/14/201635,634
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics03/11/2016163,187
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics03/14/2016177,939
KING DAVID PPresident & CEO03/11/2016335,498
Keller Deborah LCEO, Covance Drug Development03/11/2016529,753
Uthgenannt Lisa JChief Human Resources Officer03/11/2016390,241
BELINGARD JEAN-LUCDirector02/25/201676,944
BELINGARD JEAN-LUCDirector02/25/2016142,225
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics02/16/2016417,746
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/16/201638,117
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics02/11/2016136,383
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics02/12/2016217,990
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics02/12/2016275,729
KING DAVID PPresident & CEO02/12/2016384,780
KING DAVID PPresident & CEO02/11/2016280,675
Dodson Edward TPrincipal Accounting Officer02/12/201618,750
Dodson Edward TPrincipal Accounting Officer02/11/201621,497
EISENBERG GLENN AChief Financial Officer, EVP02/11/201656,277
EISENBERG GLENN AChief Financial Officer, EVP02/12/201652,746
BERBERIAN LANCESVP, Chief Information Officer02/11/201652,018
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/12/201618,235
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/11/201623,119
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/12/201641,176
EBERTS F SAMUEL IIIChief Legal Officer, Secretary01/08/2016144,646
EBERTS F SAMUEL IIIChief Legal Officer, Secretary12/08/2015124,543
Williams R SandersDirector11/02/2015119,177
Williams R SandersDirector11/02/2015229,949
ANDERSON KERRII BDirector10/29/201576,944
KING DAVID PPresident & CEO08/03/20154,018,500
KING DAVID PPresident & CEO08/03/20156,396,358
HERRING JOSEPH LCEO of Covance Drug Division07/31/20151,220,202
KING DAVID PPresident & CEO07/01/20154,018,500
KING DAVID PPresident & CEO07/01/20156,089,040
EISENBERG GLENN AChief Financial Officer, EVP06/16/2015192,286
KING DAVID PPresident & CEO06/01/20154,018,500
KING DAVID PPresident & CEO06/01/20155,928,845
MITTELSTAEDT ROBERT E JRDirector05/19/201576,944
MITTELSTAEDT ROBERT E JRDirector05/19/2015154,254
Williams R SandersDirector05/11/2015113,914
BELINGARD JEAN-LUCDirector04/29/201576,992
BELINGARD JEAN-LUCDirector04/29/2015189,820
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics04/23/2015176,425
Brecher Mark ECMO, LabCorp Diagnostics03/30/201521,892
Brecher Mark ECMO, LabCorp Diagnostics03/30/20151,697,520
Brecher Mark ECMO, LabCorp Diagnostics03/31/201544,069
Brecher Mark ECMO, LabCorp Diagnostics03/30/20152,574,921
KING DAVID PPresident & CEO03/30/2015505,811
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics03/30/2015161,900
Dodson Edward TPrincipal Accounting Officer03/30/201521,892
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/30/201521,892
Boyle James T. Jr.EVP, Chief Operating Officer03/02/2015139,397
Boyle James T. Jr.EVP, Chief Operating Officer03/03/2015153,015
Dodson Edward TPrincipal Accounting Officer03/02/201518,997
Brecher Mark EChief Medical Officer03/02/201518,997
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/02/201519,121
KING DAVID PPresident & CEO03/02/2015433,610
Williams R SandersDirector02/26/2015281,025
HERRING JOSEPH LCEO of Covance Drug Division02/25/20154,485,436
Dodson Edward TPrincipal Accounting Officer02/12/201520,798
KING DAVID PPresident & CEO02/12/2015460,934
Brecher Mark EChief Medical Officer02/12/201520,681
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/12/201520,798
EISENBERG GLENN AChief Financial Officer, EVP02/12/201559,588
Boyle James T. Jr.EVP, Chief Operating Officer02/12/2015267,213
Boyle James T. Jr.EVP, Chief Operating Officer02/13/2015452,991
Boyle James T. Jr.EVP, Chief Operating Officer02/12/2015316,751
Dodson Edward TPrincipal Accounting Officer02/11/201524,747
Boyle James T. Jr.EVP, Chief Operating Officer02/11/2015156,652
Brecher Mark EChief Medical Officer02/11/201524,863
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/11/201526,614
EISENBERG GLENN AChief Financial Officer, EVP02/11/201564,785
KING DAVID PPresident & CEO02/11/2015380,773
BELINGARD JEAN-LUCDirector02/10/201517,424
KING DAVID PPresident & CEO09/22/20144,933,647
KING DAVID PPresident & CEO09/22/20146,830,741
Williams R SandersDirector09/05/2014215,906
KING DAVID PPresident & CEO08/22/20144,933,572
KING DAVID PPresident & CEO08/22/20146,921,482
KING DAVID PPresident & CEO07/22/20144,933,572
KING DAVID PPresident & CEO07/22/20146,885,411
Boyle James T. Jr.EVP, Chief Operating Officer06/09/20143,275,596
Boyle James T. Jr.EVP, Chief Operating Officer06/09/20143,975,800
Hayes William BChief Financial Officer, EVP06/06/20144,185,380
Hayes William BChief Financial Officer, EVP06/06/20144,936,965
EBERTS F SAMUEL IIIChief Legal Officer, Secretary06/06/2014600,400
EBERTS F SAMUEL IIIChief Legal Officer, Secretary06/06/20141,043,700
Brecher Mark EChief Medical Officer06/04/2014266,006
Williams R SandersDirector05/08/2014157,643
Rubenstein Arthur HDirector05/08/2014157,643
Schechter Adam HDirector05/08/2014157,643
NEUPERT PETER MDirector05/08/2014157,643
MITTELSTAEDT ROBERT E JRDirector05/08/2014157,643
LANE WENDY EDirector05/08/2014157,643
BELINGARD JEAN-LUCDirector05/08/201415,834
BELINGARD JEAN-LUCDirector05/08/2014157,643
ANDERSON KERRII BDirector05/08/2014157,643
WEIKEL M KEITHDirector05/08/2014157,643
WEIKEL M KEITHDirector05/07/201476,979
WEIKEL M KEITHDirector05/07/2014194,979
BELINGARD JEAN-LUCDirector04/30/201476,979
BELINGARD JEAN-LUCDirector04/30/2014195,782
Hayes William BChief Financial Officer, EVP04/30/2014245,680
LANE WENDY EDirector04/30/201438,490
LANE WENDY EDirector04/30/201438,599
MITTELSTAEDT ROBERT E JRDirector04/30/2014153,971
MITTELSTAEDT ROBERT E JRDirector04/30/2014346,923
Boyle James T. Jr.EVP, Chief Operating Officer03/27/2014225,492
Boyle James T. Jr.EVP, Chief Operating Officer03/28/2014247,966
Brecher Mark EChief Medical Officer03/27/201432,199
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/27/201432,199
Hayes William BChief Financial Officer, EVP03/27/2014223,437
KING DAVID PPresident & CEO03/27/2014703,979
Hayes William BChief Financial Officer, EVP03/07/20141,626,427
Hayes William BChief Financial Officer, EVP03/06/2014440,119
Hayes William BChief Financial Officer, EVP03/07/20141,811,187
Boyle James T. Jr.EVP, Chief Operating Officer03/03/2014147,221
Boyle James T. Jr.EVP, Chief Operating Officer02/28/201473,429
Brecher Mark EChief Medical Officer02/28/201414,125
Hayes William BChief Financial Officer, EVP02/28/201472,400
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/28/201414,125
KING DAVID PPresident & CEO02/28/2014329,074
Boyle James T. Jr.EVP, Chief Operating Officer02/12/2014186,145
Boyle James T. Jr.EVP, Chief Operating Officer02/13/2014372,266
KING DAVID PPresident & CEO02/12/2014359,280
Brecher Mark EChief Medical Officer02/12/201417,650
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/12/201416,740
Hayes William BChief Financial Officer, EVP02/12/201484,975
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/10/201412,972
Brecher Mark EChief Medical Officer02/10/201412,972
Hayes William BChief Financial Officer, EVP02/10/201454,810
Boyle James T. Jr.EVP, Chief Operating Officer02/10/201454,445
Boyle James T. Jr.EVP, Chief Operating Officer02/11/2014109,745
KING DAVID PPresident & CEO02/10/2014203,254
KING DAVID PPresident & CEO01/27/20141,452,968
KING DAVID PPresident & CEO01/27/20142,181,637
KING DAVID PPresident & CEO12/24/20131,501,000
KING DAVID PPresident & CEO12/24/20132,269,750
Brecher Mark EChief Medical Officer11/25/201342,248
KING DAVID PPresident & CEO11/25/20131,501,000
KING DAVID PPresident & CEO11/25/20132,650,300
EBERTS F SAMUEL IIIChief Legal Officer, Secretary11/11/2013585,700
EBERTS F SAMUEL IIIChief Legal Officer, Secretary11/11/20131,058,350
KING DAVID PPresident & CEO10/24/20131,501,000
KING DAVID PPresident & CEO10/24/20132,522,801
Boyle James T. Jr.EVP, Chief Operating Officer10/17/20131,892,772
Boyle James T. Jr.EVP, Chief Operating Officer10/17/20132,488,800
KING DAVID PPresident & CEO09/25/20131,501,000
KING DAVID PPresident & CEO09/25/20132,476,615
KING DAVID PPresident & CEO08/26/20131,501,000
KING DAVID PPresident & CEO08/26/20132,415,047
MITTELSTAEDT ROBERT E JRDirector08/21/2013719,592
KING DAVID PPresident & CEO07/24/20131,501,000
KING DAVID PPresident & CEO07/24/20132,442,897
KING DAVID PPresident & CEO06/24/20131,501,000
KING DAVID PPresident & CEO06/24/20132,466,533
Boyle James T. Jr.EVP, Chief Operating Officer06/07/20134,426,465
Boyle James T. Jr.EVP, Chief Operating Officer06/07/20136,286,653
Brecher Mark EChief Medical Officer05/28/20131,045,235
Brecher Mark EChief Medical Officer05/28/20131,705,548
BELINGARD JEAN-LUCDirector05/24/20136,022
Hayes William BChief Financial Officer, EVP05/21/20139,880,836
Hayes William BChief Financial Officer, EVP05/21/201312,720,000
EBERTS F SAMUEL IIIChief Legal Officer, Secretary05/17/2013478,900
EBERTS F SAMUEL IIIChief Legal Officer, Secretary05/17/2013984,700
BELINGARD JEAN-LUCDirector05/13/20135,131
Boyle James T. Jr.EVP, Chief Operating Officer05/10/20133,591,261
Boyle James T. Jr.EVP, Chief Operating Officer05/10/20136,464,866
BELINGARD JEAN-LUCDirector05/08/201376,993
BELINGARD JEAN-LUCDirector05/08/2013235,544
WEIKEL M KEITHDirector05/03/201364,142
WEIKEL M KEITHDirector05/03/2013190,086
LANE WENDY EDirector04/29/201338,617
LANE WENDY EDirector04/29/201338,496
EBERTS F SAMUEL IIIChief Legal Officer, Secretary04/25/2013140,760
Williams R SandersDirector04/24/2013119,177
Williams R SandersDirector04/24/2013173,477
Hayes William BChief Financial Officer, EVP04/11/20131,559,715
Hayes William BChief Financial Officer, EVP04/11/20132,112,230
KING DAVID PPresident & CEO03/28/20131,549,636
Fonseca LidiaChief Information Officer03/28/201378,654
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/28/201378,654
Hayes William BChief Financial Officer, EVP03/28/2013503,316
Brecher Mark EChief Medical Officer03/28/201381,451
Boyle James T. Jr.EVP, Chief Operating Officer03/28/2013494,657
KING DAVID PPresident & CEO02/28/2013313,024
Boyle James T. Jr.EVP, Chief Operating Officer02/28/201369,994
Hayes William BChief Financial Officer, EVP02/28/201369,019
Brecher Mark EChief Medical Officer02/28/201313,822
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/28/201313,822
Fonseca LidiaChief Information Officer02/28/201313,822
KING DAVID PPresident & CEO02/11/2013370,597
Brecher Mark EChief Medical Officer02/11/201328,999
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/11/201327,919
Fonseca LidiaChief Information Officer02/11/201327,919
Boyle James T. Jr.EVP, Chief Operating Officer02/11/2013116,898
Hayes William BChief Financial Officer, EVP02/11/2013119,329
MAC MAHON THOMAS PDirector09/06/20123,141,044
MITTELSTAEDT ROBERT E JRDirector08/27/201276,993
MITTELSTAEDT ROBERT E JRDirector08/27/2012224,715
Brecher Mark EChief Medical Officer07/13/20121,152,768
Brecher Mark EChief Medical Officer07/13/20121,932,395
Fonseca LidiaChief Information Officer07/13/20121,092,728
Fonseca LidiaChief Information Officer07/13/20121,729,000
KING DAVID PPresident & CEO07/09/20125,039,942
KING DAVID PPresident & CEO07/09/20127,810,928
Fonseca LidiaChief Information Officer06/27/2012151,830
EBERTS F SAMUEL IIIChief Legal Officer, Secretary06/04/2012224,504
BELINGARD JEAN-LUCDirector05/11/20122,081
BELINGARD JEAN-LUCDirector05/14/20122,560
LANE WENDY EDirector05/09/201232,510
LANE WENDY EDirector05/09/201243,851
LANE WENDY EDirector05/08/201239,747
LANE WENDY EDirector05/08/201269,170
BELINGARD JEAN-LUCDirector05/07/20123,220
BELINGARD JEAN-LUCDirector05/01/201264,971
BELINGARD JEAN-LUCDirector05/01/2012119,218
Walton Andrew ScottEVP04/09/2012367,280
Boyle James T. Jr.EVP, Chief Operating Officer03/26/2012764,149
KING DAVID PPresident & CEO03/26/20122,544,711
Hayes William BChief Financial Officer, EVP03/26/2012931,590
Hayes William BChief Financial Officer, EVP03/26/2012192,913
Hayes William BChief Financial Officer, EVP03/26/2012247,500
Hayes William BChief Financial Officer, EVP03/27/20121,259,587
Walton Andrew ScottEVP03/26/2012459,408
Brecher Mark EChief Medical Officer03/26/2012147,683
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/26/2012143,272
Fonseca LidiaChief Information Officer03/26/2012143,272
Hayes William BChief Financial Officer, EVP03/23/20124,749,612
Hayes William BChief Financial Officer, EVP03/23/20126,866,831
MAC MAHON THOMAS PDirector02/29/20125,398,812
Walton Andrew ScottEVP02/10/201241,954
Walton Andrew ScottEVP02/09/201266,872
Hayes William BChief Financial Officer, EVP02/09/2012119,006
Hayes William BChief Financial Officer, EVP02/10/201279,947
Boyle James T. Jr.EVP, Chief Operating Officer02/10/201241,954
Boyle James T. Jr.EVP, Chief Operating Officer02/09/2012116,795
KING DAVID PPresident & CEO02/10/2012285,395
KING DAVID PPresident & CEO02/09/2012434,851
Fonseca LidiaChief Information Officer02/10/201215,665
Fonseca LidiaChief Information Officer02/09/201227,265
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/10/201215,665
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/09/201227,265
Brecher Mark EChief Medical Officer02/10/201216,566
Brecher Mark EChief Medical Officer02/09/201269,175
KING DAVID PPresident & CEO01/25/20121,171,400
KING DAVID PPresident & CEO01/25/20121,840,000
KING DAVID PPresident & CEO12/02/2011957,800
KING DAVID PPresident & CEO12/02/20111,760,000
MITTELSTAEDT ROBERT E JRDirector08/18/201164,971
MITTELSTAEDT ROBERT E JRDirector08/18/201165,329
Williams R SandersDirector05/19/2011477,798
Williams R SandersDirector05/19/2011633,769
EBERTS F SAMUEL IIIChief Legal Officer, Secretary05/13/20111,196,976
EBERTS F SAMUEL IIIChief Legal Officer, Secretary05/13/20111,505,479
BELINGARD JEAN-LUCDirector05/12/20113,000
BELINGARD JEAN-LUCDirector05/11/201164,938
BELINGARD JEAN-LUCDirector05/11/2011187,298
BELINGARD JEAN-LUCDirector05/09/20112,954
BELINGARD JEAN-LUCDirector05/06/20113,611
LANE WENDY EDirector04/25/201132,579
LANE WENDY EDirector04/25/201132,469
KING DAVID PPresident & CEO04/25/2011695,368
Brecher Mark EChief Medical Officer04/21/2011124,558
MAC MAHON THOMAS PDirector04/14/20114,166,260
MAC MAHON THOMAS PDirector04/15/20116,083,490
MAC MAHON THOMAS PDirector04/15/20118,048,482
MAC MAHON THOMAS PDirector04/14/20116,757,855
Walton Andrew ScottEVP04/14/2011145,825
Walton Andrew ScottEVP04/11/2011142,372
Walton Andrew ScottEVP03/30/2011162,995
Boyle James T. Jr.EVP, Chief Operating Officer03/30/201171,425
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/30/201154,667
Fonseca LidiaChief Information Officer03/30/201154,667
KING DAVID PPresident & CEO03/30/2011979,982
Hayes William BChief Financial Officer, EVP03/30/2011362,892
Hayes William BChief Financial Officer, EVP03/31/2011489,866
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/14/201112,370
Hayes William BChief Financial Officer, EVP02/14/201178,255
Hayes William BChief Financial Officer, EVP02/15/2011105,640
Walton Andrew ScottEVP02/14/201131,320
KING DAVID PPresident & CEO02/14/2011213,623
Fonseca LidiaChief Information Officer02/14/201112,370
Boyle James T. Jr.EVP, Chief Operating Officer02/14/201112,370
Hayes William BChief Financial Officer, EVP02/11/2011160,934
Hayes William BChief Financial Officer, EVP02/09/201165,151
Hayes William BChief Financial Officer, EVP02/10/201177,817
Hayes William BChief Financial Officer, EVP02/10/20111,823,235
Hayes William BChief Financial Officer, EVP02/10/20112,805,425
KING DAVID PPresident & CEO02/09/2011188,467
KING DAVID PPresident & CEO02/10/2011236,169
Conrad Andrew JEVP, Chief Scientific Officer02/10/201145,093
Conrad Andrew JEVP, Chief Scientific Officer02/09/201145,007
Brecher Mark EChief Medical Officer02/10/201116,142
Brecher Mark EChief Medical Officer02/09/201197,545
Walton Andrew ScottEVP02/10/201140,882
Walton Andrew ScottEVP02/09/201137,385
Fonseca LidiaChief Information Officer02/10/201115,616
Fonseca LidiaChief Information Officer02/09/201115,517
Boyle James T. Jr.EVP, Chief Operating Officer02/10/201140,882
Boyle James T. Jr.EVP, Chief Operating Officer02/09/201162,157
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/10/201115,616
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/09/201115,517
Hayes William BChief Financial Officer, EVP12/27/20101,823,175
Hayes William BChief Financial Officer, EVP12/27/20102,670,702
MAC MAHON THOMAS PDirector12/01/20108,380,750
MAC MAHON THOMAS PDirector12/01/201013,175,000
Walton Andrew ScottEVP10/29/201071,361
Walton Andrew ScottEVP10/29/201071,361
Walton Andrew ScottEVP10/29/201071,361
Walton Andrew ScottEVP10/29/201071,361
Hayes William BChief Financial Officer, EVP10/13/20101,757,100
Hayes William BChief Financial Officer, EVP10/13/20102,400,000
Walton Andrew ScottEVP10/06/2010292,850
Walton Andrew ScottEVP10/06/2010397,500
Walton Andrew ScottEVP10/01/201069,599
Walton Andrew ScottEVP10/01/201069,599
MITTELSTAEDT ROBERT E JRDirector09/08/201064,938
MITTELSTAEDT ROBERT E JRDirector09/08/2010140,906
Conrad Andrew JEVP, Chief Scientific Officer07/26/2010453,347
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2022
06/30/2022
-0.96%
1Q
09/30/2022
03/31/2022
-1.70%
2Q
09/30/2022
12/31/2021
-5.23%
3Q
09/30/2022
09/30/2021
-5.62%
4Q
09/30/2022
06/30/2021
-6.10%
5Q
09/30/2022
03/31/2021
-6.19%
6Q
09/30/2022
12/31/2020
-5.71%
7Q
09/30/2022
09/30/2020
-5.81%
8Q
09/30/2022
06/30/2020
-5.42%
9Q
09/30/2022
03/31/2020
-4.94%
10Q
09/30/2022
09/30/2019
-6.48%
12Q
09/30/2022
06/30/2019
-6.76%
13Q
09/30/2022
03/31/2019
-7.14%
14Q
09/30/2022
12/31/2018
-9.94%
15Q
09/30/2022
09/30/2018
-10.38%
16Q
Load More

Period of Report: 09/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2022
-0.96%
1Q
03/31/2022
-1.70%
2Q
12/31/2021
-5.23%
3Q
09/30/2021
-5.62%
4Q
06/30/2021
-6.10%
5Q
03/31/2021
-6.19%
6Q
12/31/2020
-5.71%
7Q
09/30/2020
-5.81%
8Q
06/30/2020
-5.42%
9Q
03/31/2020
-4.94%
10Q
09/30/2019
-6.48%
12Q
06/30/2019
-6.76%
13Q
03/31/2019
-7.14%
14Q
12/31/2018
-9.94%
15Q
09/30/2018
-10.38%
16Q
Load More
BUYBACK ANNOUNCEMENT(S)
Date Announced
12/09/2021 (Announcement)
Market Cap at Announcement
$27.24B
Price on Announcement
$284.67
Buyback/Market Cap (%)
9.18%
Buyback Amount
$2.50B
Buyback Shares
8,782,099
Buyback Type
New
Repurchase Method
Market Price
Date Announced
12/09/2021 (Announcement)
Market Cap at Announcement
$27.24B
Price on Announcement
$284.67
Buyback/Market Cap (%)
9.18%
Buyback Amount
$2.50B
Buyback Shares
8,782,099
Buyback Type
New
Repurchase Method
Market Price